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ABSTRACT 
 
 
TITLE OF THE ABSTRACT            : Midline Vs transverse incisions for hemi and segmental                                                                                                                           
       colectomies – a randomized controlled trial 
 
DEPARTMENT                                :   General Surgery unit 2 
NAME OF THE CANDIDATE      :   Titus D.K. 
DEGREE AND SUBJECT              :   MS General Surgery 
NAME OF THE GUIDE                 :   Dr. Benjamin Perakath 
 
OBJECTIVES:  
 
To compare the effect of transverse and midline incisions for colectomies on:   
 Duration of hospital stay 
 Post operative pain  
 Pulmonary function recovery  
 Pulmonary infection 
 Bowel function recovery 
 Wound infection  
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METHODS: 
A randomized double blinded controlled trial was carried out on 53 patients over 2 
years, comparing midline and transverse incisions for hemi and segmental colectomies.  
Patients were randomized into midline or transverse incision groups.   The mean difference 
in hospital stay was estimated with 95% confidence interval using two sample independent t 
test. Other outcomes were compared either using t-test or chi- square test, as appropriate. The 
difference was considered significant if p value was less than 0.05. 
 
RESULTS:  
 
Duration of hospital stay was shorter in the transverse group than the midline group with a p 
value of 0.016. Among secondary outcomes pain score was significantly less (p- 0.0001) in 
the transverse group (mean - 1.59) than the midline group (mean -2.62). Pulmonary function 
recovery and bowel function recovery were not significantly different.   There was a trend for 
early recovery in both parameters in the transverse group. Length of incision is significantly 
(p-0.0003) less in the transverse group (mean 10.39 cm) than the midline group (mean- 12.04 
cm). 
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Midline Vs transverse incisions for 
hemi and segmental colectomies – a 
randomized controlled trial 
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 Certain diseases of the colon necessitate excision of the whole or part of the colon; referred 
to as colectomy. In hemi or segmental colectomies only part of the colon is excised. 
Traditionally, hemicolectomies and segmental colectomies are done using a midline incision 
as they are easy to perform and can be extended if needed. However, studies have shown that 
midline incisions for abdominal surgery are associated with prolonged hospital stay, poor 
post operative recovery, higher rate of wound infection and incisional hernia. On the other 
hand, other studies have shown that transverse incisions for abdominal operations are 
associated with less post operative pain, better pulmonary function and earlier recovery.   
They have also shown that transverse incisions do not cause any difficulty in access during 
the operation (1).  
  
Colectomies are done for benign or malignant conditions. The most common colonic 
condition   which requires surgical intervention is colonic cancer. Colonic cancer is a disease 
with a major worldwide burden. It is the fourth most frequently diagnosed malignancy in 
both sexes with almost 1 million people developing colorectal cancer annually. It is the third 
most common cause of cancer death in the world, responsible for 630,000 deaths annually. In 
the United States, it is the third most common cancer in men and women, and the second 
most common cause of cancer death overall(2). In Asian countries the burden of colorectal 
cancers was less compare to developed countries. In India the incidence of colorectal cancer 
among men is 4.3 and women is 3.4 per 100,000 (3). Among colorectal cancers the rectum 
has the high incidence of malignancy (4).  
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Table 1:   Relative incidence of colorectal cancers based on anatomical location 
Site Distribution (%) 
Appendix 0.5 
Caecum 12 
Ascending colon 5 
Hepatic flexure 2 
Transverse colon 5.5 
Splenic flexure 3 
Descending colon 4 
Sigmoid colon 21 
Rectum 38 
Anus 2 
 
 
The main stay of treatment for colonic malignancy is surgical resection of the tumour. 
Surgery is based on the anatomic location of the tumour. The intent of surgery is to remove 
the primary tumour with adequate margin along with its regional lymphnodes. Lymphatic 
drainage of colon runs along its venous drainage  so resection is based on its blood supply(5). 
The commonest operations performed on the colon are summarized in the table below(6). 
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Table 2: Common operations performed in colon 
TUMOUR 
LOCATION 
RESECTION EXTENT MAJOR BLOOD VESSEL 
Caecum Right  
hemicolectomy 
Terminal ileum to mid 
transverse colon 
Ileocolic, right colic , right 
branch of middle colic artery 
Ascending colon Right 
hemicolectomy 
Terminal ileum to mid 
transverse colon 
Ileocolic, right colic, right 
branch of middle colic artery 
Hepatic flexure Extended right 
hemicolectomy 
Terminal ileum to 
splenic flexure 
Ileocolic, right colic , middle 
colic artery 
Transverse colon  Extended right 
hemicolectomy 
Terminal ileum to 
splenic flexure 
Ileocolic, right colic, middle 
colic artery 
 Transverse colon 
resection 
Transverse colon  
including both 
flexures 
Middle colic artery 
Splenic flexure Extended left 
hemicolectomy 
Right flexure to 
rectosigmoid junction 
Middle colic, left colic, inferior 
mesenteric artery 
Descending colon Left 
hemicolectomy 
Splenic flexure to 
recto sigmoid junction 
Left branch of middle colic , 
inferior mesenteric artery 
Sigmoid colon Sigmoid colon 
resection  
Descending colon to 
rectum 
Inferior mesenteric , superior 
hemorrhoidal artery 
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Rarely, benign conditions which are not amenable to medical treatment may require surgical 
intervention, the commonest of which are tuberculosis and inflammatory bowel disease.   
Whether the operation is done for benign or malignant conditions early recovery plays an 
important role in post operative outcome. There are several parameters which can influence 
post operative recovery. These factors can be pre operative, intra operative or post operative. 
Modifications of these factors for early recovery  is known as Enhanced Recovery after 
Surgery(7). Few recommendations from enhanced recovery after surgery are(8) 
Pre operative recommendations 
1) Pre-operative counseling and training. 
2) A curtailed fast (6 hours to solids and 2 hours to clear liquids) and pre-operative 
carbohydrate loading. 
3) Avoidance of mechanical bowel preparation. 
4) Deep vein thrombosis prophylaxis using low molecular weight heparin. 
5) A single dose of prophylactic antibiotics covering both aerobic and anaerobic pathogens. 
 
Per operative recommendations 
1) High (80%) inspired oxygen concentration in the peri-operative period. 
2) Prevention of hypothermia. 
3) Goal directed intra-operative fluid therapy. 
4) Preferable use of short and transverse incisions for open surgery. 
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5) Avoidance of post-operative drains and nasogastric tubes. 
6) Short duration of epidural analgesia and local block  
Post operative recommendations 
1) Avoidance of opiates and the use of Paracetamol and non steroidal anti-inflammatory 
drugs (NSAIDS). 
2) Early commencement of post-operative diet. 
3) Early and structured post-operative mobilization. 
4) Administration of restricted amounts of intravenous fluid. 
5) Regular audit. 
 One of the per operative recommendations is transverse incision for laparotomy(8). Though 
transverse incisions are theoretically recommended in literature, there is no statistically 
significant evidence in literature to support the premise that transverse incisions are better for 
early recovery (9). For hemi and segmental colectomies, there are only 2 randomized 
controlled trials in literature which compare parameters like post operative pain, pulmonary 
function recovery, wound infection and hospital stay(10). However, no studies have shown a 
statistically significant difference in these parameters between midline and transverse 
incisions for colectomies. There are no randomized controlled trials comparing all types of 
colectomies. In this study we have compared midline and transverse incisions for right and 
left hemi colectomies and segmental (transverse or sigmoid) colectomies.  
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Aim 
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To compare the effect of transverse incisions with midline incisions on early post operative 
recovery among patients undergoing elective right / left hemicolectomy or segmental 
colectomy. 
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Objectives 
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To compare the effect of transverse and midline incisions in adults undergoing elective hemi or 
segmental colectomies on the following:   
 
Primary objective:  
 Duration of hospital stay 
Secondary objectives: 
 Post operative pain  
 Pulmonary function recovery  
 Pulmonary infection 
 Bowel function recovery 
 Wound infection  
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A well planned incision is fundamental for any operation. A good abdominal incision is one 
that can be made relatively quickly, gives good exposure of intra-abdominal viscera, can 
easily be extended, is associated with few postoperative complications, and provides the 
greatest strength to the abdominal wall. Finally, a good cosmetic result should also be a 
goal(1).  
 Abdominal incisions for laparotomy can be divided into vertical and transverse incisions. 
Comparing both incisions, transverse incisions appear to have a better anatomical basis, 
based on the following features. 
 Anatomical closure 
Langer’s lines of cleavage cross the skin of the anterior abdominal wall in a transverse 
direction. An incision parallel to these lines will therefore cause the least structural and 
cosmetic damage to the skin. The musculature of the anterior abdominal wall is composed of 
two groups, the ―flat muscles‖ (the external oblique, the internal oblique, and the transverse) 
and the rectus muscles(1). The fascial fibres of the anterior abdominal wall lie in a transverse 
direction. In the midline, fibres join and form a relatively avascular linea alba. Fibres in the 
linea alba also run in transverse direction(11).  A vertical incision therefore divides them, and 
suture closure of such vertical wounds places the suture material between the fibres. 
Contraction of the abdominal wall causes laterally-directed tension on the closure line and 
might cause the suture material to cut through by separation of the transversely orientated 
fibres. In contrast, a transverse incision opens the fascia along the fibres so that closure places 
the suture material around fascial fibres. On contraction, the fibres are approximated and the 
suture material causes minimal laterally-directed tension. Sectioning of one or both rectus 
muscle has no serious anatomical or physiological consequences. When healed, the muscles 
will have an extra tendinous intersection without functional impairment (1) .  
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 Blood supply 
 The blood supply to the abdominal wall is taken care of by two systems. Firstly, the inferior 
and superior epigastric arteries form a longitudinal anastomosis, which is called the deep 
epigastric arcade. The arcade is situated between the rectus abdominis muscle and its 
posterior sheath and supplies the muscle by perforating vessels. Some of these perforating 
vessels send small branches across the midline to supply the linea alba. Secondly, blood 
supply to the oblique and transverse muscles is taken care of by transverse segmental arteries 
that arise from the aorta and are situated between the internal oblique and transverse muscles. 
These segmental arteries follow a slightly downward transverse direction(11).  Transection of 
the epigastric arteries has no physiological consequences for the blood supply to the 
abdominal wall, as the deep circumflex iliac artery and the lumbar and intercostal arteries 
also contribute to the anastomosis .  
 Nerve supply 
The innervation of the abdominal wall consists of ventral branches of the 5th to 12th thoracic 
nerves and the iliohypogastric and ilioinguinal nerves.   They lie between the transverse 
muscle and the internal oblique muscle, where they form a free plexus. The ninth intercostal 
nerves pass transversely across the abdomen at a point one third the distance between the 
umbilicus and the xiphoid process. Nerves above this line tend to deviate upward, while those 
below deviate downwards. When an incision is made lateral to the midline, the transverse 
direction is least likely to cause injury to the nerves(1).  
 
However, traditionally, abdominal operations for colectomies are performed through midline 
incisions.  Six studies have  compared  midline and transverse incisions for elective right 
hemicolectomies(10,12–15), and one study for left hemicolectomy(16). Two of these studies 
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were randomized controlled trials. There is also a systematic review comparing midline and 
transverse incisions for all abdominal operations(9). 
In literature, the first study comparing midline and transverse incisions was published in 2000 
by Stipa.  It was a non randomized study, 44 patients were included and 27 of them had 
midline incision and 17 had transverse incision.  Pain, bowel function recovery, duration of 
hospital stay and complications were the outcomes assessed. Pain was less and bowel 
function recovery was faster in the transverse incision group but the difference was not 
statistically significant. Duration of hospital stay was assessed by how many patients were 
discharged on the 8
th
 post operative day. In midline group only 4% were discharged but in 
transverse group 47% were discharged by the 8
th
 day which was statistically significant (p 
value 0.001) (15).  
In 2001, Lindregen and co workers published a randomized controlled trial comparing 
midline and transverse incisions for right colonic malignancy, with post operative pain and 
pulmonary function as major outcomes. In this study, out of 40 patients, 17 had transverse 
incisions and 23 had midline incisions. They concluded that transverse incision group had  
less post operative pain and early pulmonary function recovery(14). 
Donati published a retrospective study in 2002 comparing midline and skin crease   incisions 
for right hemicolectomy.  It was a retrospective study, in which, out of 123 patients, 62 had a 
skin crease incision and 61 had a midline incision. It showed skin crease incision group had 
statistically significant quicker bowel function recovery, early fluid and solid intake and 
shorter hospital stay. They failed to show any difference in post operative complications, pain 
and narcotic requirements. They also showed a statistically significant decrease in length of 
skin incision and duration of operation in the skin crease incision group. (13).Brown has done 
a randomized controlled trial on 28 patients undergoing right hemicolectomy comparing 
midline and transverse incisions. Fourteen patients were randomized in each group. It was 
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concluded that there was no statistically significant difference in analgesic requirement, 
bowel function recovery and duration of hospital stay. There was a significant decrease in 
wound length in the transverse incision group (10). 
Lohsiriwat from Thailand published a retrospective non randomized study in 2009. He 
compared 74 patients who underwent right hemicolectomy out of which 54 had midline 
incisions and 20 had transverse incisions. He found that transverse incisions had statistically 
significant reduction in analgesic requirement and hospital stay compared to the midline 
group. He did not find any significant difference in bowel function recovery and post 
operative complications(12). 
Recently, in 2012 a retrospective study was published comparing midline and right Kochers’ 
incision for right hemicolectomy. They found that duration of hospital stay was less in 
Kochers’ incision group, but analgesic requirements, pulmonary compromise, bowel function 
recovery and post operative complications were the same in both groups (17). 
 A retrospective study by Kam was published in 2004.  He compared 280 patients (140 
midline incisions; 140 left skin crease incisions) who underwent elective, curative resection 
of left–sided colorectal cancers. Postoperative parameters for the skin crease incision group 
showed that feeding, ambulation, narcotic use and hospital stay were significantly better than 
the parameters in the midline group (16). 
Most of these studies were retrospective and only 2 were prospective randomized controlled 
trials with the maximum sample size of 40. There are no systematic reviews comparing 
midline and transverse incision for colectomies. 
However, the Cochrane database has a systematic review for all abdominal operations, 
comparing   midline and transverse incisions. In this review there were 16 randomized 
controlled trials done for various abdominal operations including emergencies. Two 
randomized controlled trials done for right hemicolectomy were also included in this 
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systematic review.  There were many confounding factors between the studies which made it 
difficult to analyze. All the studies did not have the same objectives and outcomes, and 
different methods were used in assessing the outcomes, so achieving a statistical significant 
outcome was difficult. However, results showed a trend towards transverse incision being 
better (9).Since most of these findings were not statistically significant, the authors concluded 
that analgesia use and pulmonary compromise may be reduced with a transverse/oblique 
incision but this does not seem to be significant clinically, as pulmonary complication rates 
and recovery times were the same. The wound dehiscence and rupture appears to be reduced 
with a transverse incision. The optimal incision for abdominal surgery still remains the 
preference of the surgeon (9).  
 
There are no studies comparing all types of colectomies in the literature and the available 
randomized controlled trials for right hemi colectomies had small sample size. All studies are 
from developed countries, and there are no studies from the Indian population.  
 
Our study is a properly structured randomized controlled trial in the Indian population 
comparing midline and transverse incision for hemi and segmental colectomies. Duration of 
hospital stay was taken as the primary outcome as this would represent early recovery from 
surgery. All the other parameters which could be influenced by the incision, and could 
potentially affect hospital stay were considered as secondary outcomes. 
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Methods 
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Type of study: Randomized controlled trial 
Period of study: 2 years (September 2010 – August 2012) 
Sample size calculation: 
Sample size for this study was calculated based on a study by Lohsriwat which had hospital 
stay as primary out come and showed statistically significant less hospital stay in the 
transverse incision group(12). 
                 Hospital stay 
                     Mean +/- S.D in midline group = 7.9+/_ 3.2  
                     Mean +/- S.D in transverse group = 6+/_2.5 
                     Difference = 1.9 days 
                                             Power = 80% 
                                             Level of significance = 5%  
                                                        (Z1-α/2 + Z1-β)^2  *  2σ^2  
                     Formula(18)     n =      ____________________ 
                                                                         d^2 
 
1. Alpha (typically 5% (sometimes written =0.05) (19);   also known as the false-
positive rate. 
2. Adequate power for a trial is widely accepted as 0.8 (or 80%). Power is 
defined as 1-where , the false-negative rate, in this case would be 0.2 (or 20%). 
3. Where the primary outcome is a continuous measurement such as blood pressure, an 
estimate of the natural variability in the population needed, usually the standard deviation, σ. 
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4. Where z(1-/2) and z(1-) represent percentage points of the normal distribution for 
statistical significance level and power, respectively.  
5. d represents the standardized difference (i.e. the treatment difference divided by its 
standard deviation) (18,19). 
 
Based on above values and formula, the calculated sample size is 36 in each arm. 
 
Pre operative work up: 
 Pre operatively participants had contrast enhanced CT scan to assess the operability and 
metastatic state. Pre anesthesia check up was done for all to assess the ASA grade.  
The ASA physical status classification system is a system for assessing the fitness of patients 
before surgery. In 1963 the American Society of Anesthesiologists (ASA) adopted the five-
category physical status classification system; a sixth category was later added (20).         
These are: 
1- A normal healthy patient. 
2- A patient with mild systemic disease. 
3- A patient with severe systemic disease. 
4- A patient with severe systemic disease that is a constant threat to life. 
5- A moribund patient who is not expected to survive without the operation. 
6- A declared brain-dead patient whose organs are being removed for donor purposes. 
Participants had a baseline spirometry and chest x-ray pre operatively. This was done so that  
pre operative values could be compared to post operative values, as a measure of pulmonary 
function (21). None of the participants had oral mechanical bowel preparation. However, for 
left hemicolectomies the participant had an enema on the day before surgery. 
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Participants:  
All participants who were to undergo elective hemi or segmental colectomies under General 
Surgery Unit 2 and 4 in Christian Medical College hospital were included in this study, using 
following criteria: 
.  
a. Inclusion criteria:  
 Elective operations for benign and malignant 
colonic disease 
 No evidence of intra abdominal metastasis in 
malignant disease preoperatively as confirmed 
by CT scan. 
 ASA grade 1-3(20) 
 
 
 
b. Exclusion criteria:  
 Emergency operations 
 Palliative operations 
 ASA grade > 3(20) 
 Metastatic disease 
o Multiple liver metastasis  
o Gross ascites  
o Serosal and peritoneal deposits 
  Patients planned for  stoma pre operatively 
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             All participants who fulfilled the inclusion criteria were given an information sheet in 
a language they could read and understand after which informed consent was taken. 
Participants who refused to give consent were excluded from the study and had traditional 
midline incision. 
Randomization: 
Patients were randomized into midline group and transverse group.  
Block randomization codes were generated using a computer program (raloc)(22).  
Concealment: 
             Opaque, sealed, unmarked, sequential   envelopes opened just before operation were 
used for allocation concealment (23). 
 
 
Blinding and masking: 
          This was a double blinded study in which the participant and the outcome assessor 
were blinded (24). 
           Specific protocols were followed for all participants regarding analgesia, antibiotics 
and dressings as outlined below.   
             Intra operatively all participants received epidural analgesia adequately covering the 
incisions. The level of epidural catheter placement was left to the anaesthetist. A premixed 
solution of Inj. Fentanyl and Inj. Bupivacaine was used for infusion(25).  The participant 
received a single dose of Inj. Cefazolin 1 gm, Inj. Flagyl 500mg and Inj. Gentamicin 160mg 
or Inj. Ciprofloxacin 200mg depending upon renal status just before skin incision.  
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             The sealed envelope was opened and type of incision was read out to the surgeon. 
The operation was performed in the usual manner. Post operatively, a vertical as well as 
transverse dressing was placed on the operating table. This was done to blind the pain score 
assessor regarding type of incision. Pain score was assessed by a nurse twice daily using a 
visual analogue scale and documented. 
              Post - operatively the participant was given oxygen at 6litres/ min for 6 hours. No 
post operative antibiotics were administered. Chest physiotherapy, steam inhalation and 
incentive spirometry were given to all participants throughout their hospital stay.  
Analgesia protocol: 
Epidural analgesia was removed after 72 hours. Change in epidural dose or early removal of 
epidural was documented in the epidural chart. Inj/Tab.  diclofenac 50 mg q8h or Inj/Tab. 
Tramadol 50mg q8h were used for post epidural analgesia, depending on renal function. 
While on the epidural infusion, Inj  diclofenac 50mg or Inj Tramadol 50 mg were used for 
breakthrough analgesia. After epidural removal Inj. Morphine 0.1mg/kg subcutaneously was 
used for breakthrough analgesia. The participant also received Inj Paracetamol 1 gram six 
hourly while in hospital post operatively. If any other mode of analgesia was used, the reason 
was documented clearly. 
                
 
Primary outcome:  
 Duration of hospital stay: 
Transverse incisions are thought to result in less post operative pain and less pulmonary 
complications, resulting in early ambulation and discharge. Therefore hospital stay was used 
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as primary outcome. However, to avoid co morbid conditions and other factors which could 
influence the duration of hospital stay, duration of hospital stay was calculated from the day 
of operation to the day the patient was deemed fit enough to be discharged. Fitness was 
decided by the surgical team using these criteria: 
 Afebrile for 24 hrs 
 Taking normal diet  
 Passed stools and flatus post operatively 
 No intra venous fluid 
If hospital stay was prolonged due to co morbid conditions that was mentioned separately. 
Re- admission or reoperation was also noted. 
Secondary outcomes:  
 Post operative pain 
This was assessed by documenting the pain score using visual analog scale 
twice daily during the hospital stay. The dose of epidural required for 
analgesia was calculated and whether breakthrough analgesia was required or 
not assessed and if required, the number of doses noted. We also documented 
the mode of analgesia used after removal of the epidural catheter. The above 
mentioned guidelines for analgesic use were followed for all participants.  
 Pulmonary function recovery 
Pulmonary function status was assessed by spirometry. One baseline 
spirometry was done preoperatively in the pulmonary function lab. Post 
operatively this was repeated twice, one at 24 hours and one at 72 hours. 
Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 minute (FEV1) 
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and FEV1 and FVC ratio were measured for both groups using a portable 
spirometer (21).  
 Pulmonary infection 
                             Pulmonary  infection was diagnosed by using modified 
CDC criteria for nosocomial pneumonia(26,27). 
Acute nosocomial pneumonia is broadly defined as pneumonia characterized 
by a new and persistent infiltrate (radiographically present for greater than 48 
hours) PLUS 
Two of the following: 
* Core temperature > 38.3°C 
* Blood leukocytes > 10,000 cells/mL 
* Purulent tracheal secretions 
 
 Total white cell counts were checked at 72 hours. The patient was assessed 
for purulent tracheal secretion and rise in temperature. If 2 out of 3 of these 
criteria were present, participant was subjected to a chest x ray and, if positive 
findings suggestive of pulmonary infection were present, the chest x- ray was 
repeated after 48 hours. If the criteria were fulfilled, the participant was 
diagnosed to have pulmonary infection 
 Bowel motility recovery 
This was assessed by time taken to pass flatus and faeces post operatively, 
calculated in hours from the end of operation.  
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 Wound infection 
This was diagnosed using CDC criteria for surgical site infection (28).  
WOUND INFECTION DIAGNOSTIC CRITERIA 
Surgical site infection (SSI) 
Superficial incisional SSI 
Infection occurs within 30 days after the operation and infection involves only skin or 
subcutaneous tissue of the incision and at least one of the following: 
           1. Purulent drainage, with or without laboratory confirmation. 
           2. Organisms isolated from an aseptically obtained culture of fluid or tissue. 
           3. At least one of the following signs or symptoms of infection: pain or tenderness, 
localized swelling, redness, or heat. Superficial incision deliberately opened by surgeon, 
unless incision is culture-negative. 
            4. Diagnosis of superficial incisional SSI by the surgeon or attending physician. 
Deep incisional SSI 
Infection occurs within 30 days after the operation, infection involves deep soft tissues (e.g., 
fascial and muscle layers) of the incision and at least one of the following: 
1. Purulent drainage from the deep incision but not from the organ/space component 
of the surgical site. 
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2. A deep incision spontaneously dehisces or is deliberately opened by a surgeon 
when the patient has at least one of the following signs or symptoms: fever (>38° C), 
localized pain, or tenderness, unless site is culture-negative. 
3. An abscess or other evidence of infection involving the deep incision is found on 
direct examination, during reoperation, or by histopathologic or radiologic examination. 
4. Diagnosis of a deep incisional SSI by a surgeon or attending physician. 
1. Report infection that involves both superficial and deep incision sites as deep incisional 
SSI. 
2. Report an organ/space SSI that drains through the incision as a deep incisional SSI. 
Wound infection was diagnosed based on these criteria by the surgical team every day. 
 
Other parameters which were compared: 
 Length of incision 
Measured in centimeters at the end of surgery by the operating surgeon 
or first assistant and documented 
 Duration of surgery in minutes 
Calculated from skin incision to closing of skin written by the 
operating surgeon or first assistant at the end of surgery 
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 Resected pathology specimens were assessed for 
o Nodal status 
o Margin status 
o TNM staging if malignant(29) 
 
These parameters were assessed to study the difficulty and accessibility while using these 
incisions. 
 Rate of readmission  
o Reason and post operative day were 
noted 
 Rate of re exploration 
o Reason and post operative day were 
noted 
These factors were assessed to compare immediate operative complications in both groups. 
       
Statistical analysis:  
The primary outcome variable for this study was the duration of hospital stay. The 
mean duration between the two study groups were compared using two-sample independent -
t- test. The mean difference in hospital stay was estimated with 95% confidence interval. The 
secondary outcome variables were compared between the two groups either using t-test or 
chi- square test, as appropriate. The difference was considered significant if p value was less 
than 0.05(24). 
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Participants’ flow chart  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients assessed for 
eligibility 
70? 
Refused to give consent 
and failed to fulfill inclusion 
criteria 17 
Randomized 53 
Allocated to midline incision group- 
25 
 
Allocated to transverse incision 
group -28 
 
 
Lost to follow up or excluded from 
study - 0 
Lost to follow up or excluded from 
study - 0 
 
Analyzed for primary outcome -24 
Excluded from analysis- 1 
Reason – had reoperation in the 
same hospital stay 
Analyzed for primary outcome- 25 
Excluded from analysis -3  
Reason – had reoperation in the same 
hospital stay 
 
Reason – had reoperation in the same 
hospital stay 
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Recruitment  
All patients who underwent hemi or segmental colectomies for benign or malignant 
conditions under General Surgery unit 2 and 4 in Christian Medical College Hospital Vellore, 
Tamil Nadu, India from 26/08/2010 to 25/08/2012 for a period of 2 years were included in 
the study after taking informed consent. The study was stopped before completing the sample 
size as the dissertation had to be submitted as part of MS General Surgery Course. 
Base line data 
The calculated sample size was 72, 36 in each arm.  We could recruit only 53 participants in 
the given time frame. The midline incision arm had 25 participants and the transverse 
incision arm had 28 participants. 
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Age distribution: 
Among 53 participants 40% of them were in the age group of 41-50 years. Age distribution of  
the study group is given below. 
Fig1: Pie chart showing percentage distribution of patients according to age group. 
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Sex distribution 
Sixty percent of the study group was male. 
Fig.2: Pie chart showing percentage distribution of patients according to sex. 
 
Body Mass Index (BMI) 
Participants were classified into different groups according to their body weight(30,31) 
Table 3: BMI classification 
BMI value  Category  
</= 15 Very underweight 
16-18.4 Underweight 
18.5-24.9 Normal 
25-29.9 Overweight 
30-34.9 Obese 
>/=35 Very obese 
 
60.4
39.6
Sex
Male
Female
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BMI Distribution 
Forty percent of the study group fell in the overweight category. There was no one in the very 
obese category. 
 
Fig.3: Pie chart showing percentage distribution of patients according to BMI 
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Geographical distribution  
In the study group out of 53, 29 participants were from West Bengal and Bangladesh, 10 
from South India, 9 from Jharkhand and Bihar and 4 from North East states. 
 
Fig.4: Pie chart showing distribution of patients (number) based on geography. 
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Type of colectomies 
Among 53 participants, 42 participants underwent right hemicolectomy, 6 participants 
underwent extended right hemicolectomy, 4 participants had left hemicolectomies and one 
participant had sigmoid colectomy. 
 
Fig.:5 Pie chart showing percentage of patients according to type of colectomies  
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Diagnosis: 
Among 53 participants 45 participants had malignant disease and 8 had benign pathology 
 
Fig.6: Pie chart showing benign and malignant cases in the study group 
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Demographic profile 
Demographic profile was compared between both groups and summarized below 
Table4: Demographic profile summary 
Demographic 
profile 
value 
Midline incision 
group 
Transverse 
incision group 
p value 
Age  Mean(95% C.I) 
47 (40.69 -   
53.30) 
49.75(45.08 -   
54.41) 
 
0.47 
Sex male No (%) 17(68) 15(53.57)  
0.28 Sex female No (%) 8(32) 13(46.43) 
BMI Mean(95% C.I) 
21.85(20.04 -    
23.66) 
21.87(20.65     
23.08) 
 
0.99 
 
Co-morbidities 
Conditions which can affect any of the primary or secondary outcomes have been assessed in 
co morbidities. Assessment of pulmonary function and pulmonary infection can be affected 
by diseases like asthma, COPD or any other lung diseases (32–34).  Diseases like diabetes 
mellitus, previous history of chemotherapy or radiotherapy will affect the wound healing 
process and they may be prone for surgical site infection (35,36). Duration of hospital stay 
and wound infection rate can be affected by these diseases.  Previous abdominal surgery can 
cause intra abdominal adhesions and prolong the duration of surgery (37).  These parameters 
were compared between both groups and summarized below. 
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Table5: Co morbidities - summary 
Parameters 
Midline incision Transverse incision 
p - Value 
n % n % 
Asthma 
   Yes 
   No 
 
- 
25 
 
- 
100.0 
 
- 
28 
 
- 
100.0 
 
1.000 
COPD 
   Yes 
   No 
 
2 
23 
 
8.00 
92.00 
 
1 
27 
 
3.57 
96.43 
 
0.486 
Diabetes   
   Yes 
   No 
 
3 
22 
 
12.00 
88.00 
 
5 
23 
 
17.86 
82.14 
 
0.35 
Pre op Chemo 
   Yes 
   No 
 
- 
25 
 
- 
100.0 
 
1 
27 
 
3.57 
96.43 
 
0.340 
Pre op RT 
   Yes 
   No 
 
- 
25 
 
- 
100.0 
 
1 
27 
 
3.57 
96.43 
 
0.340 
Previous abdominal surgery 
   Yes 
   No 
 
8 
17 
 
32.00 
68.00 
 
12 
16 
 
42.86 
57.14 
 
0.416 
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Duration of operation  
Some authors feel that transverse incision does not give good access to the tumour. In this 
study duration of operation was compared between both the groups to see whether the 
transverse incision group took longer to complete the operation. The mean time for midline 
and transverse group was 145.8 minutes and 135.53 minutes respectively. The duration of 
operation was shorter in the transverse incision group. The difference was not statistically 
significant. 
Duration of operation 
Table 6: Comparison of duration of operation between the midline and the transverse 
group 
Group N Mean (hrs) S.D. Minimum Maximum p - Value 
Midline incision  25 145.8 34.51 90 240 
0.24 
Transverse incision  28 135.53 28.52 90 195 
 
Length of incision  
The length of incision was measured between both groups and compared. Mean length of 
incision in transverse group was 10.39 cm. In midline group it was 12.04 cm and this 
difference was statistically significant (p-0.0003). 
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Table 7: Comparison of length of incision between the midline and the transverse group 
Group N 
Mean 
(cms) 
S.D. Minimum Maximum p - Value 
Midline incision  25 12.04 2.19 9 20 
0.0003 
Transverse incision  28 10.39 2.02 8 18 
 
Type of anastomosis: 
For joining the ends of the bowel sutures or staples were used. In the midline group out of 25 
participants only 22 had anastomosis. Nineteen of them had hand sewn anastomosis and three 
had a stapled anastomosis. In the transverse incision group, out of 28, 27 had anastomosis and 
5 of them had a stapled anastomosis, the other 22 had hand sewn anastomosis. This was 
compared between both groups and the difference was not statistically significant. 
Fig.7: Bar diagram showing type of anastomosis in both the groups 
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Diagnosis 
Benign and malignant diseases were compared between both the groups. The midline group 
had 19 malignant conditions and 6 benign conditions. The transverse group on the other hand 
had 24 malignant conditions and only 4 benign conditions.  This difference was not 
statistically significant (p value -0.367). 
 
Fig.8: Bar diagram showing percentage distribution of benign and malignant condition 
in both the groups 
 
 
 
 
 
 
 
p- 0.36 
 
 
 
76
85.71
24
14.29
0
10
20
30
40
50
60
70
80
90
Midline Transverse
P
e
rc
e
n
ta
ge
Malignancy
Benign
 
 
50 
 
 
Stoma creation  
All patients who were planned for stoma pre operatively were excluded from this study. 
However participants who were planned for primary anastomosis but had to have a stoma 
because of various reasons were included. In the transverse incision group, only 1 person had 
stoma, but in midline group 3 participants had a stoma; this difference was not statistically 
significant (P value – 0.638). 
 
Fig.9:  Bar diagram showing number of patients who had stoma creation in both the 
groups. 
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Table 8: Summary of intra operative parameters  
Parameter 
Value 
measured 
Midline 
incision group 
Transverse 
incision group 
p value 
Benign No (%) 6 (24) 4 (14.29)  
0.367 Malignant No (%) 19 (76) 24 (85.71) 
Length of 
incision 
Mean (p25-p75) 12.04 (9, 20) 10.39 (8, 18) 0.0003 
Hand sewn 
anastomosis 
No (%) 19 (86.4) 22 (81.5) 
 
0.646 Staple 
anastomosis 
No (%) 3 (13.6) 5 (18.5) 
Stoma  No (%) 3 (12) 1 (3.7) 0.638 
Duration of 
operation 
Mean (min, 
max) 
145.8 (90, 240) 135.53 (90, 195) 0.24 
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Oncological Assessment  
Number of nodes 
The oncological stage and resection status were compared in those who had malignant 
disease.  
The total number of nodes resected was compared between both groups, the midline group 
had a mean value of 16.78 nodes and transverse group had a mean value of 15.83 and the 
difference was not significant. 
Table 9:  Comparison of Number of nodes harvested between the midline and the 
transverse incision group 
Group n Mean (n) S.D. Minimum Maximum p – Value 
Midline incision  18 16.78 7.63 8 38 
0.87 
Transverse incision  24 15.83 6.44 6 37 
 
TNM stage 
Malignant tumours were compared for their TNM staging (29) and the difference was not 
statistically significant. 
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T – Tumor size 
In both groups most tumours were T3 or T4 tumours. In the midline group, 10 participants 
were T3 and 5 were T4. In the transverse incision group 14 participants were T3 and 9 T4. 
This difference was not significant (p = 0.556).  
 
Fig.10: Bar diagram comparing tumour size in both the groups 
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N – Nodal status 
In the midline group, out of 18 participants, 9 were N0, 4 were N1 and 5 were N2. In the 
transverse group, out of 24 participants, 13 were N0, 7 were N1 and 4 were N2.   
 
Fig.11 Bar diagram comparing nodal status between both the groups 
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Stage 
The midline incision group had 50% stage II disease and transverse incision group had 52% 
stage III disease. However this difference was not statistically significant (p = 0.50). 
 
Fig.12: Percentage distribution of patients among the different stages in the midline and 
the transverse incision group.  
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Table 10: Summary of oncological resection comparison 
Parameter 
Value 
measured 
Midline 
incision group 
Transverse 
incision group 
p value 
Positive 
proximal 
margin 
No (%) 0 (0) 0 (0) 
 
Positive distal 
margin 
No (%) 0 (0) 0 (0) 
 
No of nodes 
resected 
Mean (p25-p75) 16.78 (8, 38) 15.83 (6, 37) 0.87 
T stage 
Tis No (%) 1 (5.56) 0(0)  
 
0.556 
T1 No (%) 1 (5.56) 0(0) 
T2 No (%) 1 (5.56) 1 (4.17) 
T3 No (%) 10 (55.56) 14 (58.33) 
T4 No (%) 5 (27.28) 9 (37.50) 
N stage 
N0 No (%) 9 (50) 13 (54.17)  
0.665 N1 No (%) 4 (22.22) 7 (29.17) 
N2 No (%) 5 (27.28) 4 (16.67) 
TNM 
stage 
I No (%) 2 (11.76) 1 (4.17) 
 
0.502 
II No (%) 6 (35.29) 12 (50) 
III No (%) 9 (52.94) 11 (45.83) 
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History of smoking 
Pulmonary function recovery and pulmonary infection have been assessed as secondary 
outcomes in this study. Pulmonary function recovery was assessed using spirometry.  Present 
or past history of smoking can affect the values of pulmonary function tests(38,39). However 
in this study difference in their distribution between both groups were statistically 
insignificant. 
Smoking Status 
In midline group there were 3 smokers and transverse group had 2 smokers 
 
Fig13: Bar diagram comparing percentage of smokers and non smokers in both the 
groups 
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Ex smokers 
There were two and three ex smokers in midline and transverse group respectively. 
 
Fig.14: Bar diagram comparing ex smokers and non smokers in both the groups 
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Outcomes 
Duration of Hospital Stay 
Duration of hospital stay was calculated from the day of operation to the day when the patient 
was declared fit for discharge. However if patients underwent re operation during the same 
hospital stay, they were excluded from the calculation. After exclusion, the midline incision 
group had 24 participants and transverse incision group had 25 participants. To compare both 
groups we took quantiles into account. P50 OR Q2 otherwise known as median is the 50
th
 
percentile. P50 was taken into consideration to avoid extreme values affecting the results. 
P25 is 25
th
 percentile and p75 is 75
th
 percentile. P50 means 50% of values will be less than 
p50 value. P50duration of hospital stay in midline and transverse incision group was 6 and 5 
respectively and the difference was statistically significant. 
Table 11: Comparison of duration of hospital stay between the midline and the 
transverse group 
Group n  P50 
(days) 
P25 P75 S.D. p - Value 
Midline incision  24 6 5 6 1.10 
0.0162 Transverse 
incision  
25 5 4 6 3.50 
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Pain  
Pain was assessed using the visual analogue scale. Pain score was measured twice daily and 
the average was calculated for each day. Overall average of pain score for the patient was 
taken for calculation. The mean value in the midline group was 2.62. The transverse group 
had a mean value of 1.59. P value was 0.0001 which was statistically significant.  
Other factors that could influence the pain score were also assessed. Epidural was given to 
most patients and the day of epidural removal was noted. The day epidural was removed was 
assessed between the midline and the transverse group. There was no statistically significant 
difference in the day of epidural removal. 
 The level of epidural catheter placement was also assessed.  There was no statistically 
significant difference between the levels of   placement. The most common level the catheter 
was placed was T 10 in both groups.  
The dose of epidural was calculated everyday for all 3 days and the average dose was taken 
and compared. Mean value in the midline group was 5.04 and transverse group was 4.7. The 
p value of this was 0.16 which was not significant.  
Post epidural analgesia usage were assessed for each day between both groups and compared, 
and the difference was insignificant.  
Pain score 
Table12: Comparison of pain score between the midline and the transverse group 
Group n Mean S.D. Minimum Maximum 
p - Value 
Midline incision  25 2.62 0.76 1.2 4 0.0001 
Transverse incision  28 1.59 0.52 0.6 2.6 
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Epidural dose average  
Table13: Comparison of average epidural dose between the midline and the transverse 
group 
Group n Mean S.D. Minimum Maximum p - Value 
Midline incision  25 5.04 1.07 3.1 7.6 
0.16 
Transverse incision  26 4.70 0.56 3.4 5.9 
 
Break through analgesia (BTA) required was calculated for each day and p value was 
calculated. There was no statistically significant difference between both groups in usage of 
break through analgesia.  
Fig.15: Bar diagram comparing BTA on day1 between the midline and the transverse 
group 
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Fig.16: Bar diagram comparing BTA on day2 between the midline and the transverse 
group 
 
 
p value -0.135 
Fig.17: Bar diagram comparing BTA on day3 between the midline and the transverse 
group 
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Epidural catheter removal 
The epidural catheter was usually removed 72 hours post operatively. However, due to 
various reasons like non functioning epidural or hypotension, some epidurals were removed 
early. These parameters were also compared and there was no significant difference was 
found between the groups. 
Table 14: Comparison of day of epidural removal between the midline and the 
transverse group 
Variables 
Midline incision Transverse incision 
p - Value 
n % n % 
Epidural removed 
   Day1 
   Day2 
   Day3 
   Day4 
 
5 
1 
- 
19 
 
20.0 
4.00 
- 
76.00 
 
1 
- 
2 
23 
 
3.85 
- 
7.69 
88.46 
 
 
0.110 
 
Post epidural analgesia 
Morphine, Diclofenac or Tramadol were used for analgesia after removal of the epidural. The 
number of doses was compared in both groups for each day. There was no statistical 
difference between both groups. 
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Table 15: Comparison of post epidural analgesia usage between the midline and the 
transverse group 
Post epidural analgesia day 
No of patients received 
post epidural analgesia p value 
Midline Transverse 
1 6 5 0.649 
2 7 4 1 
3 7 6 0.28 
4 25 28 0.43 
5 21 26 1.00 
6 11 13 0.42 
 
Among all the parameters compared regarding post operative pain, only pain score showed 
statistically significant difference between both groups (p value 0.0001). The transverse 
group had less pain compared to the midline group. 
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Pulmonary function 
Pulmonary function was assessed using spirometry. Three values were calculated, Forced 
Vital Capacity, Forced Expiratory Volume at 1 minute and their ratio (FEV1/FVC). Midline 
or transverse incision will affect pulmonary function assessment by impairing diaphragmatic 
movement which results in restrictive pattern of lung pathology. FVC is a better 
representative of restrictive lung conditions(21,34). Differences in all 3 values were 
calculated between pre op and 24 hours value, pre op and 72 hours value and 72 and 24 hours 
value. These differences were compared between both groups. Out of all three parameters 
FVC between pre operative value and 24 hours was just significant (p value 0.05). The 
midline group had a mean value of 1.1, the transverse group had a mean value of only 0.75. 
FEV1 
Table 16: Comparison of FEV1 between the midline and the transverse group 
Group n Mean S.D. 95% confidence interval p - Value 
Pre op – 24hrs 
   Midline incision  
   Transverse  
 
20 
21 
 
0.962 
0.698 
 
0.09 
0.12 
 
0.76 
0.43 
 
1.15 
0.95 
 
0.103 
Pre op – 72hrs   
Midline incision  
   Transverse 
 
19 
21 
 
1.06 
0.91 
 
0.49 
0.53 
 
0.82 
     0.67 
 
1.30 
1.15 
 
0.37 
72 hrs – 24 hrs  
   Midline incision  
   Transverse 
 
18 
20 
 
0.10 
0.15 
 
0.44 
0.47 
 
-0.11 
-0.06 
 
0.31 
0.37 
 
0.71 
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FVC 
Table 17: Comparison of FVC between the midline and the transverse group 
Group n Mean S.D. 95% confidence interval p - Value 
Pre op – 24hrs 
   Midline incision  
   Transverse  
 
20 
21 
 
1.10 
0.75 
 
0.50 
0.59 
 
0.86 
0.48 
 
1.33 
1.02 
 
0.05 
Pre op – 72hrs   
Midline incision  
   Transverse 
 
19 
21 
 
1.25 
0.93 
 
0.11 
0.13 
 
1.00 
0.64 
 
1.50 
1.21 
 
0.08 
72 hrs – 24 hrs  
   Midline incision  
   Transverse 
 
18 
20 
 
0.13 
0.109 
 
0.48 
0.54 
 
-0.109 
-0.144 
 
0.37 
0.36 
 
0.88 
 
FEV1/FVC 
Table 18: Comparison of FEV1/FVC between the midline and the transverse group 
Group n Mean S.D. 95% confidence interval p - Value 
Pre op – 24hrs 
   Midline incision  
   Transverse  
 
20 
21 
 
2.58 
3.70 
 
9.2 
9.17 
 
-1.87 
-0.47 
 
7.04 
7.88 
 
0.70 
Pre op – 72hrs   
Midline incision  
   Transverse 
 
19 
21 
 
2.67 
3.7 
 
8.8 
8.2 
 
-2.01 
-0..22 
 
5.09 
5.69 
 
0.86 
72 hrs – 24 hrs  
   Midline incision  
   Transverse 
 
18 
20 
 
1.1 
-3.27 
 
9.00 
10.36 
 
-3.36 
-8.12 
 
5.57 
1.57 
 
0.17 
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Pulmonary Infection 
There was one case each of proven pulmonary infection in both groups which was not 
statistically significant (p = 0.935) 
Fig18: Bar diagram comparing percentage of pulmonary infection between the midline 
and the transverse group 
 
. 
 
 
 
 
p value 0.935 
Time to pass flatus 
Bowel function recovery can be assessed by various methods. In this study we took 2 
parameters time to pass stools and time to pass flatus. This time was calculated from the end 
of operation in hours. The midline group had a mean value of 78.39 hours for passage of 
flatus. The transverse group had a value of 63.85. The difference was not significant.  
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Table 19: Comparison of time taken to pass flatus between the midline and the 
transverse group 
 
 
Group n Mean(hours) S.D. Minimum Maximum p - Value 
Midline incision  23 78.39 64.08 36 360 
0.17 Transverse 
incision  
27 63.85 32.02 34 192 
 
Time to pass faeces 
Midline group had a mean value of 99.43 hours for passage of faeces, transverse had a mean 
value of 86.85 hours only. However this difference was not significant.  
Table 20: Comparison of time taken to pass faeces between the midline and the 
transverse group 
Group n Mean(hours) S.D. Minimum Maximum p – Value 
Midline incision  23 99.43 65.42 43 384 
0.53 Transverse 
incision  
27 86.85 34.62 39 216 
 
 
 
 
 
69 
 
Wound Infection 
Wound infection was compared between both groups. Out of 25 patients in the midline group 
4 had post operative wound infection. In the transverse group, out of 28 participants 9 had 
wound infection. Even though wound infection was higher in transverse group it was not 
significant.  Most of the wound infection was diagnosed on 4
th
 post operative day in both 
groups. 
Fig.19: Bar diagram comparing wound infection between the midline and the transverse 
group 
 
 
 
 
 
p value 0.17 
Time to wound infection 
Table 21: Comparison of time to wound infection between the midline and the 
transverse group  
Group n Mean(days) S.D. Minimum Maximum p - Value 
Midline incision  4 3.75 0.5 3 4 
0.29 
Transverse incision  9 4.22 0.83 3 6 
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Table 22: Summary of outcomes 
Outcome 
Value 
measured 
Midline 
incision group 
Transverse 
incision group 
P value 
Duration of hospital 
stay 
P50(p25,p75) 6 (5,6) 5 (4,6) 0.0162 
Post op pain 
Mean (min – 
max) 
2.62 (1.2,4) 1.59 (0.6, 2.6) 0.0001 
Pulmonary 
function 
recovery 
FVC 
Pre op 
– 24 
hours 
Mean(95% C.I) 1.1 (0.86, 1.33) 
0.75 (0.48, 
1.02) 
0.05 
Pre op 
– 72 
hours 
Mean(95% C.I) 1.25 (1, 1.5) 
0.93 (0.64, 
1.21) 
0.08 
72- 24 
hours 
Mean(95% C.I) 
0.13 (-0.10, 
0.37) 
0.109 (-0.14, 
0.36) 
0.88 
Pulmonary infection No (%) 2 (4) 2 (3.57) 0.935 
Bowel 
function 
recovery 
Time to 
pass 
flatus 
Mean (min, 
max) 
78.39(36, 360) 63.85 (34, 192) 0.17 
Time to 
pass 
stools 
Mean (min, 
max) 
99.43 (43, 384) 86.85 (39, 216) 0.53 
Wound infection No (%) 4 (16) 9(32.14) 0.17 
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Complications  
Reoperation and re admission and their causes were compared in both groups. There were 3 
reoperations in both groups; all were done for suspected anastamotic leak. 
Reoperation 
Fig 20: Bar diagram comparing no of readmissions between the midline and the 
transverse group 
 
 
                                                                p value 0.92 
Time to reoperation 
In the midline group the mean operation post op day was 8 and in the transverse group it was 
6. However this difference was not significant. 
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Table 23: Comparison of time to reoperation between the midline and the transverse 
group 
Group n Mean(days) S.D. Minimum Maximum p - Value 
Midline incision  3 8.33 3.51 5 12 
0.35 
Transverse incision  3 6 1.73 5 8 
 
Re admission  
Readmissions were calculated in both the groups, the post operative day of readmission and 
the reason for readmission was documented. There were only 2 readmissions in both groups 
and their mean readmission day was 7 and 8 in midline and transverse group respectively. 
However this difference was not statistically significant. 
Fig.21: Bar diagram showing percentage of re admissions in both the groups 
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Re admission day 
Table 24: Comparison of readmission post operative day between the midline and the 
transverse group 
 
Group n Mean(days) S.D. Minimum Maximum p - Value 
Midline incision  3 7.33 5.03 2 12 
0.77 
Transverse incision  2 8.5 0.71 8 9 
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Discussion 
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In this study, we have compared transverse and midline incisions for colectomies. Literature 
on this suggests that transverse incisions are better in terms of post operative pain, pulmonary 
compromise, bowel function recovery, post operative complications and duration of hospital 
stay, but randomized trials are rare. The few trials that are available have small sample sizes. 
This is the first such study with such a large sample size, in an Indian population, comparing 
all types of colectomies. 
In this study, duration of hospital stay is considered as primary outcome. In our practice, we 
follow an Enhanced Recovery After Surgery (ERAS) programme for all patient who have 
major colorectal resection.  While transverse incisions have been described as a component of 
ERAS, it is not clear how much this contributes to recovery and shorter hospital stay. We 
wished to study whether transverse incision further shortened hospital stay.  
 Parameters like post operative pain, pulmonary function compromise, wound infection, 
pulmonary infection and bowel function recovery were considered as secondary outcomes. 
They were considered secondary outcomes because they can influence the primary outcome.  
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 Duration of hospital stay 
Our primary outcome was duration of hospital stay.  Duration of hospital day was calculated 
from the day of the operation till the date the patient was fit on discharge. To avoid 
confounding factors like participants willingness to stay longer or billing and insurance issues 
which could prolong the hospital stay, separate criteria were followed to assess the fitness for 
discharge. The patient should have been: 
 afebrile for 24 hrs 
 on a  normal diet  
 Passed stools and flatus post operatively 
 off intra venous fluids 
Among the 7 studies available in literature(10,12–17),  6 had duration of hospital stay as 
outcome(10, 12, 13,15–17).  Brown and coworkers did not find any difference in duration of 
hospital stay (10). The other studies found significant difference in favour of transverse 
incision. Stipa calculated duration of hospital stay as the percentage of patients discharged in 
both groups on 8
th
 post operative day. Forty seven percent of patients with transverse 
incisions were discharged on the 8
th
 day in transverse group. The midline group had only 4% 
of the patients discharged on the 8
th
 post operative day (15). Lohsiriwat’s study had a median 
hospital stay of 6 days in transverse group and 7.9 days in midline group(12).Theodosopoulos  
and coworkers  had similar findings with median value of 5 days in the transverse group and 
8 days in the midline group(17). Donati and Kam also found significantly lower hospital stay 
in transverse group(13,16).  
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None of the studies had any specific criteria to calculate duration of hospital stay. We used 
the above mentioned criteria to calculate the duration of hospital stay. After excluding the 
patients who had re operation during the same admission, midline group had 24 participants 
and transverse group had 25 participants. Midline group had a median hospital stay of 6 days. 
Transverse group had a median hospital stay of 5 days. This difference was statistically 
significant with a p value of 0.01. 
           The benefits are reduced hospital stay, decreased cost to the patient, decreased cost to 
the hospital, increased earnings for the hospital and reduced hospital infection. Transverse 
incision lead to all these benefits by contributing to reduced hospital stay.  
It is to be noted that, within the ERAS programme in our institution, the mean duration of 
hospital stay for even the midline group is 6 days. This is much shorter than that reported in 
literature. Most studies have shown an 8 day hospital stay. 
Pain 
Among secondary outcomes, post operative pain was assessed using several parameters like  
 visual analogue scale  
 level of epidural insertion,  
 change in epidural dosage and the reason,  
 date of epidural removal, break- through analgesia if used,  
 number of doses and the analgesics used,  
 Post epidural analgesia, (whether tablet or injections) and use of any other mode of 
analgesia.   In this study pain was assessed by a blinded assessor, not involved in the 
study. Pain score average was calculated each day and overall average was compared 
between both the groups.  
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Stipa found that 7 out of 12 patients in the transverse group had no or mild pain. In the 
midline group 11 out of 27 patients had no or mild pain. Lindgren compared pain between 
both groups at rest and after physical exercise. He found that the transverse group had less 
pain score as well as analgesic requirements (15).  
Lohsiriwat found that the use of intravenous narcotics was less in the transverse group 
compared to midline group(12). Similar findings were mentioned for left hemicolectomy by 
Kam(16).  Brown did not find any difference in pain score or analgesic requirements in his 
randomized controlled trial (10).  
In our study we did not find any difference in analgesic requirements, break through 
analgesia or post epidural analgesia. The mean pain score was calculated after measuring 
scores twice a day. Scores were compared between both groups.  However, the pain score 
was significantly less in the transverse incision group. The midline group had a value of 2.62 
and the transverse group had a score of 1.59 and this was statistically significant (0.0001).  
Pulmonary function recovery 
Pulmonary function was assessed using spirometry. Three important parameters assessed in 
spirometry are FVC, FEV1 and FEV1/FVC. These help to distinguish restrictive from 
obstructive disease. Any abdominal operation will affect pulmonary function by impeding the 
movement of diaphragm. This type of impairment causes restrictive pulmonary compromise. 
Among the parameters assessed, FVC is the better indicator of restrictive pathology (21). 
Pulmonary function impairment due to an incision depends on how cranial the incision is and 
severity of post operative pain. Normally, midline incisions extend more cranially than 
transverse incisions.  
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In this study, we assumed that a transverse incision would cause less pulmonary impairment. 
To prove this, spirometry was done for participants’ pre operatively, and then 24 hours and 
72 hours post operatively. These parameters were compared and the difference was 
calculated. 
In this study FEV1, FEV1/FVC or FVC did not show any statistically significant difference 
between the two groups.   
In literature, only one study has assessed pulmonary function compromise by spirometry. 
Lindgren found that immediate post operative pulmonary function was compromised in both 
groups. However, the parameters recovered better in transverse group than midline group 
(14). 
However, in our study FVC value difference between pre operative and 24 hours post 
operative in midline group was 1.10 and 0.75 in transverse group. It showed a trend towards 
the transverse incision being better though this was not statistically significant. The 
difference between pre operative and 72 hours did not show any significant difference 
between both groups.  
This indicates that transverse incisions probably compromise pulmonary function less than 
midline incisions; however it was not statistically significant and was not reproducible after 
72hours post operation. A larger sample size might produce a statistically significant 
difference. 
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Pulmonary infection 
Pulmonary infection was diagnosed based on the criteria for hospital acquired pneumonia. 
This is one of the simplest criteria to diagnose pulmonary infection. In our study there were 
only 2 cases of pneumonia, one in each arm. 
In literature there were 3 studies that analyzed pulmonary infection. Lohsiriwat had one 
pulmonary infection in midline group (12). Theodosopoulos had 7 pulmonary infection in 
midline group and 6 in transverse group (17). However this was not statistically significant.  
Lindgren concluded that transverse incision might produce less pulmonary complications 
(14). However in our study we did not find any difference. 
Wound infection 
Among wound related complications, wound infection and dehiscence are the early 
complications and incisional hernia a late complication. In this study we assessed only wound 
infection. Wound infection was diagnosed based on CDC criteria (28).   
Lohsiriwat in his retrospective study had one wound infection in the transverse group and 
four in midline group. Theodosopoulos had two wound infections in each group. They did not 
find any statistically significant difference (17).  
In our study, we had 9 out of 28 wound infection in transverse group and 4 out of 25 in 
midline group. This difference again was not significant.  
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Bowel function recovery 
Recovery of bowel function is often difficult to assess. Assessment can be in several ways. 
It can be time taken to pass stools or flatus post operatively, time to start oral fluids, normal 
diet or stopping of intra venous fluids.  Stipa assessed bowel function recovery by assessing 
time to pass stools and he did not find any significant difference (15). Lohsiriwat, 
Theodosopoulos, Brown and Donati compared bowel function recovery along with time to 
start oral fluid and solid diet(10,12,13,17). Donati found a statistically significant difference 
in bowel function recovery, starting of oral fluid and solid diet (13). The others did not find 
any significant difference. In our study we assessed time taken to pass flatus and faeces. The 
midline group had a mean value of 78.39 hours for passing flatus. The transverse group took 
63.85 hours. Similarly, time to pass faeces also was faster in the transverse group (86.65 
hours Vs 99.43 hours).   
Even though there was a trend of early bowel function recovery in transverse group this 
difference was not significant (p value 0.17 and 0.53 respectively).  
 However, there were limitations with the use of time taken to pass flatus and faeces. Factors 
like anastomotic leaks or diarrhea secondary to pelvic collections can affect the outcome 
analysis.   
Adequacy of oncological resection 
Proximal and distal resection margins were compared in both arms. All proximal and distal 
margins were negative in both groups, implying that extent of resection is adequate with 
transverse incisions.  
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The number of nodes resected in both groups was compared. Transverse group had a mean 
value of 15.83 nodes. Midline group had 16.78. The p value was 0.87, which was not 
significant.  
There was no difference in the adequacy of oncological resection between both groups. 
TNM staging 
TNM staging was also compared between both groups to see whether one group had early 
stage disease. 
In the midline group 55% of tumours were T3 and in the transverse group 58% were T3. The 
difference was not significant (p-0.556). 
Fifty percent of participants had N0 disease in midline group, and 54% participants had N0 
disease in transverse group.  
In midline group 52% of participants had TNM stage III disease, but transverse group 50% of 
patients had stage II disease. However this difference was not significant (p-0.5). 
There was no difference in TNM stage distribution between both groups. 
Length of incision  
 Shorter incisions will cause less post operative pain, less analgesic requirements and 
eventually will help in early recovery. So length of incision was assessed, and the transverse 
incision group had a mean length of 10.39 cm, the midline incision group had a mean length 
of 12.04cm. The difference was statistically significant with a p value of 0.0003. 
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Duration of operation 
Duration of operation was also compared between the two groups. Duration of operation was 
shorter in the transverse incision group, though statistically insignificant.  
Thus, transverse incisions are easy to perform, provide adequate access, do not compromise 
on oncological clearance, and are shorter in length than midline incisions. 
Complications 
Complications like wound infection and pulmonary infection were assessed as secondary 
outcomes. However other complications like re-operation, anastomotic leak and re 
admissions were also compared.  
Both groups had 3 reoperations each and in all cases the reason for reoperation was suspected 
anastomotic leak. There was no significant difference in the post operative day in which the 
re- operation was done. In the same way, re admission for various reasons were compared in 
both the groups, the midline group had 3 readmissions and the transverse group had 2 re 
admissions, and the difference were not significant.  
 
 
 
  
 
  
 
 
84 
 
 
 
 
 
Limitations 
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During the course of this study, laparoscopic surgery was introduced in our unit. Hence we 
were not able to achieve our intended sample size as some of the patients had hemi or 
segmental colectomies laparoscopically. 
Post operative analgesics requirement was assessed by using a fixed protocol.Perhaps it 
would have been better to assess the use of on demand analgesia requirement.  
We had difficulty in assessing post operative bowel function recovery; factors like pelvic 
collection, electrolyte imbalance, use of opioids affected the bowel function recovery. Oral 
fluid intake and starting of solid diet was also not analyzed in our study, however these 
parameters were subjective and prone to bias. 
Due to time constraint long term complications like incisional hernia were not assessed.  
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Conclusion 
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We compared midline and transverse incisions for hemi and segmental colectomies. It was a 
randomized controlled trial with 53 participants. There were 25 participants in the midline 
group and 28 in the transverse group.  
Both groups did not show any difference in demographic profile and comorbid conditions. 
Type of anastomosis, benign malignant distribution, stoma creation duration of operation 
TNM stage distribution did not show any difference between both groups. 
Our primary outcome (duration of hospital stay) was significantly lower in the 
transverse group. Among secondary outcomes, post operative pain was significantly less 
in the transverse incision group. However analgesic requirement was the same in both 
groups.  
Pulmonary function recovery and bowel function recovery were not significantly different 
between both groups. However, there was a trend for early recovery in both parameters 
compared to midline incision in the transverse group.  
Post operative complications like wound infection, pulmonary infection, re operation and re 
admission did not show any difference between both groups. 
Length of incision was significantly shorter in the transverse incision group. Based on 
the above results we conclude that transverse incision is shorter in length, results in shorter 
hospital stay and less post operative pain compared to midline incision.   
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Annexure - 1 
INFORMATION SHEET 
 
 NAME OF THE PARTICIPANT:                                                                       DATE:                           S.NO: 
  NAME OF THE STUDY: Randomized controlled trial comparing the effect of transverse incision 
with    midline incision on post operative recovery of patients undergoing elective hemi or 
segmental colectomy 
                                         You have been diagnosed to have a disease of the large intestine and have been told 
that a part of your large intestine will have to be removed. This will require opening of the abdomen. The 
abdomen can be opened vertically in the midline or transversely.  Normally this decision is taken by the 
operating surgeon and the vertical incision is the technique used most often. However, there are studies which 
have shown that a transverse incision is associated with less post operative pain, less lung compromise, early 
recovery from surgery and reduced hospital stay without any difficulty for the surgeon and may be better for 
the patient. 
Since it is not known if transverse incisions are really better than vertical incisions, we would like to compare 
these two incisions in participants undergoing your type of operation. We plan to ask about 72 participants to 
take part in this study. Half of these participants will have a transverse incision and half will have a vertical 
incision. We will then compare the two groups of participants to see which group fared better. 
 This sheet will give you information you will need regarding this study. If you have any queries please feel free 
to ask the person whose name and contact details are given below. 
If you are willing to take part in this study you will be enrolled into the study and you will either get a vertical 
or transverse incision. You will not know which incision you will get, but you have a 50:50 chance of a vertical 
or transverse incision. You will also be asked to undergo a few tests and asked a few questions. After all 
patients have had their operation, we will assess duration of hospital stay, pain after the operation, lung 
function, the function of your bowel and wound infection. We will also assess the function of your lungs by a 
test called ‘Spirometry”. This will be done 3 times, once before your operation and twice after your operation. 
This is a procedure where you will be asked to blow air into a machine. You will also have to undergo an extra 
blood test post operatively to check your total white blood cell count. This test will be helpful in diagnosing 
pulmonary infection early. Apart from these tests, you will be given the same care that all patients undergoing 
this procedure get. You will not be asked to bear the cost for these extra investigations and this will be done 
free of cost. However, you have to pay for your regular treatment. 
                                      By taking part in this study you will be helping us to assess if a transverse incision is better 
than a vertical incision. The information we obtain during this study may be used for publication in medical 
journals. However, your personal identity will not be revealed. You have right to refuse to take part in this 
study or withdraw from this study any time you wish to. That will not affect the treatment you receive for your 
disease. If you have any doubts at any time you can contact the following person 
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Annexure- 2 
 INFORMED CONSENT FORM 
 
Study Title: TRANSVERSE Vs MIDLINE INCISION FOR RIGHT, LEFT AND SEGMENTAL 
COLECTOMIES 
 
Study Number:__________                                                                                     Date: 
 
Participant’s Name: ____________________________                                  Age:_______ 
 
Please mark          in the space provided   
 
(i) I confirm that I have read and understood the information sheet for the above study and have 
had the opportunity to ask questions.                     [           ] 
 
(ii) I understand that my participation in the study is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights being affected.   [            
]                                                                        
 
 (iii) I understand that the investigators will not need my permission to look at my health records 
both in respect of the current study and any further research that may be conducted in relation to 
it, even if I withdraw from the trial. I agree to this access. However, I understand that my identity 
will not be revealed in any information   published.          [           ] 
 
(iv) I agree not to restrict the use of any data or results that arise from this study provided such a 
use is only for scientific purposes.                             [           ] 
 
(v) I agree to take part in the above study.                             [            ] 
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Signature (or Thumb impression) of the Subject/Legally Acceptable Representative: 
_____________ 
 
Date: _____/_____/______ 
 
Signatory’s Name: _________________________________ 
 
 
Signature of the Investigator: ________________________ 
 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
 
Signature of the Witness: ___________________________ 
 
Date:_____/_____/_______ 
 
Name of the Witness: ______________________________________ 
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Annexure- 3 
PROFORMA 
DEMOGRAPHIC PROFILE 
1.NAME:________________________________              2.AGE:_______               3.SEX: M / F         
4.S.NO: 
5.ADDRESS:_____________________________ 
_______________________________________ 
6.HT:______ Ms                           7.WT:_______KGs                            8.BMI:____________ 
9.SMOKER:  YES  /  NO              10.PACK YEARS:_______        11.EX- SMOKER:  YES  /  NO      IF YES, 
12.STOPPED HOW MANY MONTHS BACK:______ 
13.ASTHMA:  YES/ NO       14.COPD:  YES  /  NO          15.ANY OTHER LUNG DISEASE: 
_________________   15.DIABETES MELLITUS: YES / NO      16.PRE OP CHEMOTHERAPY: YES / NO     
17.PRE OP RT: YES / NO 
PRE OP EVALUATION 
18.DIAGNOSIS:_________________________  19.PLANNED 
SURGERY:____________________________ 
20.DATE OF SURGERY:________________       21.ANY PREVIOUS ABDOMINAL SURGERY: YES  /  NO 
22.WHAT SURGERY:______________________________ 
INTRA OP ASSESSMENT 
23. PERFORMED SURGERY:_________              24.OPERATION START TIME:________ 
25.OPERATION END TIME:___________          26.DURATION OF SURGERY :___________(MIN) 
27.LENGTH OF INCISION :________(CM)          28.ANASTOMOSIS: STAPLE / HAND  
29.EPIDURAL LEVEL: __________  
PATHOLOGY: 
 30.NO.OF NODES REMOVED:_____________   31.TNM STAGE: ____________ 
 32.MARGIN TUMOUR INVOLVEMENT STATUS PROXIMAL: YES / NO         33.DISTAL: YES / NO 
 OUTCOME ASSESSSMENT: POST OP. PAIN – VISUAL ANALOG SCALE 
     DAY 
TIME 
DAY 1 DAY2 DAY3 DAY4 DAY5 DAY6 DAY7 DAY8 DAY9 DAY10 
34. 8:00 AM           
35. 4:00 PM           
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EPIDURAL DOSE 
DAY DAY1 DAY2 DAY3 
36.DOSE ML/HR    
37. DURATION IN HRS    
38.STOPPED? Y / N Y / N Y / N 
39.REASON    
40.STOPPED 
DURATION IN HRS 
   
41.CHANGE IN DOSE Y / N Y / N Y / N 
42.REASON    
43. CHANGED DOSE          
44. DURATION OF 
CHANGED DOSE  
         
45. TOTAL DURATION 
IN HRS 
   
46.TOTAL DOSE / DAY 
IN ML 
   
 
47.EPIDUAL REMOVED ON: _________POD 
POST EPIDURAL ANALGESIA 
DAY DAY1 DAY2 DAY3 DAY4 DAY5 DAY6 DAY7 DAY8 DAY9 DAY10 
48.DRUG           
 
BREAKTHROUGH ANALGESIA 
DAY DAY1 DAY2 DAY3 DAY4 DAY5 DAY6 DAY7 DAY8 DAY9 DAY10 
49.DRUG           
50.DOSES           
 
51.ANY OTHER MODE OF ANALGESIA USED: YES / NO     52.IF YES 
WHAT:__________________________ 
PULMONARY FUNCTION: SPIROMETRY 
VALUES PRE OP POST OP 24 HRS POST OP 72HRS 
53.VC    
54.FVC    
55.FEV1    
56.FEV1/FVC    
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PULMONARY INFECTION: 
DAY DAY1 DAY2 DAY3 DAY4 DAY5 DAY6 DAY7 DAY8 DAY9 DAY10 
57..TEMP> 38.3 C?           
58.TC > 
10,000CELLS/MM3? 
          
59..PURULENT 
SPUTUM? 
          
60.CRITERIA 
FULFILLED? 
          
61.CHEST X RAY 
DONE? 
          
62.POS. FINDING           
63.RPT X RAY 
DONE? 
          
64.CONFIRMED?           
65.PUL. INF. 
PRESENT? 
          
BOWEL FUNCTION RECOVERY 
 PASSED FLATUS AT:66.DATE_________67.TIME________68.TIME TAKEN : _____________ ( IN HRS) 
PASSED FAECES AT:  69.DATE_________70.TIME________  71.TIME TAKEN : _____________ ( IN 
HRS)  
WOUND INFECTION 
DAY DAY3 DAY4 DAY5 DAY6 DAY7 DAY8 DAY9 DAY10 11-30 
DAYS 
72.WOUND 
INFECTION? 
         
HOSPITAL STAY 
73.DECLARED FIT FOR DISCHARGE ON:____________ 
74.DURATION OF HOSPITAL STAY :___________(DAYS) 
[CALCULATED FROM OPERATION DATE TO THE DAY PATIENT FIT TO BE DISCHARGED] 
75.REOPERATION: YES / NO      IF YES  76.DAY: ______ POST OP. DAY        
77.REASON:__________________________________ 
78.READMISSION: YES / NO     IF YES      79.DAY: ______ POST OP. DAY         
80.REASON:____________________________________ 
 
81. ALLOCATION NO: ________ 
 
 
95 
 
 
 
 
 
REFERENCES 
 
 
 
 
 
 
96 
 
REFERENCES 
1.  Grantcharov TP, Rosenberg J. Vertical compared with transverse incisions in abdominal 
surgery. European Journal of Surgery. 2001;167(4):260–7.  
2.  Michael J. Zinner, MD, FACS Stanley W. Ashley, MD, FACS. Maingot’s Abdominal 
Operations > Chapter 23. Tumors of the Colon >Epidemiology. 11TH EDITION.  
3.  Colorectal cancer in India: controversies, enigmas and primary prevention K. M. 
Mohandas. Indian J Gastroenterol (Jan–Feb 2011) 30(1):3–6.  
4.  Norman S. Williams MS FRCS FMed Sci  Christopher J.K. Bulstrode MCh FRCS(Orth) 
P. RONAN O’CONNELL MD FRCSI FRCPS(Glas) Bailey & Love’s SHORT 
PRACTICE of SURGERY. 25th edition.  
5.  Charles J. Yeo, MD  Samuel D. Gross Professor and Chair, Department of Surgery, 
Thomas Jefferson University, Philadelphia, Pennsylvania. Shackelford’s Surgery of the 
Alimentary Tract>TREATMENT OF PRIMARY COLON AND RECTAL 
CARCINOMA. 6th edition.  
6.  Michael J. Zinner, MD, FACS Stanley W. Ashley, MD, FACS. Maingot’s Abdominal 
Operations > Chapter 23. Tumors of the Colon >Surgery General Technical Principles. 
11th edition.  
7.  Health D of. Enhanced recovery research and resources [Internet]. [cited 2012 Sep 16]. 
Available from: 
http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Healthcare/Electivecare/
Enhancedrecovery/DH_115765 
8.  Kahokehr AA, Sammour T, Sahakian V, Zargar-Shoshtari K, Hill AG. Influences on 
length of stay in an enhanced recovery programme after colonic surgery. Colorectal Dis. 
2011 May;13(5):594–9.  
9.  Brown SR, Goodfellow PB. Transverse verses midline incisions for abdominal surgery. 
Cochrane Database Syst Rev [Internet]. 2005 [cited 2012 Aug 18];4. Available from: 
http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD005199.pub2/pdf/standard 
10.  Brown SR, Goodfellow PJ, Adam IJ, Shorthouse AJ. A randomised controlled trial of 
transverse skin crease vs. vertical midline incision for right hemicolectomy. Tech 
Coloproctol. 2004 Mar;8(1):15–8.  
11.  J.Jeekel, M. van ;t Riet JWAB. ABDOMINAL INCISIONS : TECHNIQUES AND 
POSTOPERATIVE COMPLICATIONS. Scandinavian Journal of Surgery. 2002;315–21.  
12.  Lohsiriwat V, Lohsiriwat D, Boonnuch W, Chinswangwatanakul V, Akaraviputh T, 
Methasade A, et al. Comparison between midline and right transverse incision in right 
hemicolectomy for right-sided colon cancer: a retrospective study. J Med Assoc Thai. 
2009 Aug;92(8):1003–8.  
 
 
97 
 
13.  Donati D, Brown SR, Eu KW, Ho YH, Seow-Choen F. Comparison between midline 
incision and limited right skin crease incision for right-sided colonic cancers. Tech 
Coloproctol. 2002 Apr;6(1):1–4.  
14.  Lindgren PG, Nordgren SR, Öresland T, Hulten L. Midline or transverse abdominal 
incision for right-sided colon cancer—a randomized trial. Colorectal Disease. 
2001;3(1):46–50.  
15.  Stipa F, Barreca M, Lucandri G, Fernades E, Mercantini P, Meli L, et al. [Transverse 
minilaparotomy as an access route in right colon disease: a valid alternative to midline 
laparotomy]. Chir Ital. 2000 Feb;52(1):91–6.  
16.  Kam MH, Seow-Choen F, Peng XH, Eu KW, Tang CL, Heah SM, et al. Minilaparotomy 
left iliac fossa skin crease incision vs. midline incision for left-sided colorectal cancer. 
Tech Coloproctol. 2004 Aug;8(2):85–8.  
17.  Theodosopoulos T, Yiallourou AI, Dafnios N, Polymeneas G, Papaconstantinou I, 
Staikou C, et al. Right Kocher’s incision: a feasible and effective incision for right 
hemicolectomy. A retrospective study. World journal of surgical oncology. 2012 Jun 
7;10(1):101.  
18.  Zhong B. How to Calculate Sample Size in Randomized Controlled Trial? J Thorac Dis. 
2009 Dec;1(1):51–4.  
19.  By D Machin, M Campbell, P Fayers & A Pinol. Sample Size Tables for Clinical Studies 
(2nd Edition, 1997) - [ISBN 0-86542-870-0]. 2nd ed. published by Blackwell Science 
Ltd;  
20.  Daabiss M. American Society of Anaesthesiologists physical status classification. Indian 
J Anaesth. 2011;55(2):111–5.  
21.  Pulmonary function tests - PubMed Health [Internet]. [cited 2012 Aug 26]. Available 
from: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0004306/ 
22.  David Shen. Randomization in clinical trials. pharma surg 2006.  
23.  Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against 
deciphering. Lancet. 2002 Feb 16;359(9306):614–8.  
24.  Y H Chan. Randomised controlled trials -essentials. Singapore Med J 2003 Vol 44(2) : 
060-063. 2003; 25.  Bupivacain and Fentanyl for Epidural administration. Liverpool 
Health Service Intensive Care Unit; 2002.  
26.  Kollef MH. What is ventilator-associated pneumonia and why is it important? Respir 
Care. 2005 Jun;50(6):714–721; discussion 721–724.  
27.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, 
and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005 Feb 
15;171(4):388–416.  
28.  Guideline for prevention of surgical site infection. JULY 2000 BULLETIN OF THE 
AMERICAN COLLEGE OF SURGEONS. 2000;  
 
 
98 
 
29.  AJCC Cancer Staging Manual (Sixth ed.). Springer-Verlag New York, Inc.. 2002.  
30.  Wikipedia contributors. Body mass index [Internet]. Wikipedia, the free encyclopedia. 
Wikimedia Foundation, Inc.; 2012 [cited 2012 Sep 17]. Available from: 
http://en.wikipedia.org/w/index.php?title=Body_mass_index&oldid=512823088 
31.  Healthy Weight: Assessing Your Weight: BMI: About Adult BMI | DNPAO | CDC 
[Internet]. [cited 2012 Sep 17]. Available from: 
http://www.cdc.gov/healthyweight/assessing/bmi/adult_bmi/index.html 
32.  Bobbio A, Chetta A, Carbognani P, Internullo E, Verduri A, Sansebastiano G, et al. 
Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD 
patients after lobar pulmonary resection. Eur J Cardiothorac Surg. 2005 Nov;28(5):754–
8.  
33.  Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function 
tests. Asthma outcome. Am. J. Respir. Crit. Care Med. 1994 Feb;149(2 Pt 2):S9–18; 
discussion S19–20.  
34.  Crapo RO. Pulmonary-function testing. N. Engl. J. Med. 1994 Jul 7;331(1):25–30.  
35.  Terranova A. The effects of diabetes mellitus on wound healing. Plast Surg Nurs. 
1991;11(1):20–5.  
36.  Payne WG, Naidu DK, Wheeler CK, Barkoe D, Mentis M, Salas RE, et al. Wound 
Healing in PatientsWith Cancer. Eplasty [Internet]. 2008 Jan 11 [cited 2012 Sep 17];8. 
Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206003/ 
37.  Jyrki Kössi*,1, Markku Luostarinen1 and Matti Laato2. Laparoscopic and Open 
Colorectal Surgery in Previously Operated Patients is Associated with Considerable Need 
for Adhesiolysis. The Open Surgery Journal, 2010, 4, 7-10.  
38.  Theadom A, Cropley M. Effects of preoperative smoking cessation on the incidence and 
risk of intraoperative and postoperative complications in adult smokers: a systematic 
review. Tob Control. 2006 Oct;15(5):352–8.  
39.  Groth SS, Whitson BA, Kuskowski MA, Holmstrom AM, Rubins JB, Kelly RF. Impact 
of preoperative smoking status on postoperative complication rates and pulmonary 
function test results 1-year following pulmonary resection for non-small cell lung cancer. 
Lung Cancer. 2009 Jun;64(3):352–7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
99 
 
Variable names and codes 
v2   age                   ## 
v3   sex                   # (1-male 2-female) 
v4   s.no                  ## 
v5   address               ____________________________________________________ 
v6   ht                    #.## (metres) 
v7   wt                    ### (kgs) 
v8   bmi                   ##.# 
v9   smoker                # (1 yes 2 no) 
v10  pack years            ## 
v11  ex smoker             # (1 yes 2 no) 
v12  stopped months        ###  
v13  asthma                # (1 yes 2 no) 
v14  copd                  # (1 yes 2 no) 
v15  any other             _____________________________________________ 
v16  dm                    # (1 yes 2 no) 
v17  preop chemo           # (1 yes 2 no) 
v171 pre op rt             # (1 yes 2 no) 
v18  diagnosis             # (1 carcinoma 2 benign) 
v19  planned surgery       # 1 right 2 ex right 3 left 4 tran 5 sigmoid 
v20  dos                   <dd/mm/yyyy> 
v21  prev abd surgery      # (1- yes 2 - no) 
v22  what sx               _________________________________________ 
v23  sx                    # (1 right 2 ex right 3 left 4 tran 5 sigmoid) 
v24  stoma                 # (1 yes 2 no) 
v251 sx start time         ##.## hrs 
v252 sx end time           ##.## hrs 
v253 duration              ### min 
v26  length                ## cm 
v27  anastomosis           # 1 hand 2 staple 
v28  epidural level        # 1 t7 2 t8 3 t9 4 t10 5 t11 6 t12 7 l1 8 l2 
v29  no of nodes           ## 
v30  t                     # 
v31  n                     # 
v32  m                     # 
v33  stage                 #_ 
v34  prox margin           # (1 yes 2 no) 
v35  distal margin         # (1 yes 2 no) 
V361 VAS D1                # 
V362 VAS D2                # 
V363 VAS D3                #  
V364 VASD4                 # 
V365 vas d5                # 
v366 vas d6                # 
v367 vas d7                # 
v368 vas d8                # 
v369 vas d9                # 
v37  ave vas               #.# 
v381 epid1                 #.# ml/hr 
v382 epid2                 #.# ml/hr 
v383 epid3                 #.# ml/hr 
v391 st/ch d1              # (1 yes 2 no d1) 
v392 st/ch d2              # (1 yes 2 no d2) 
v393 st/ch d3              # (1 yes 2 no d3) 
v401 reason                # (1 not fun 2 hypo 3 paralysis 4 othr 5 inadequate 6 less pain d1) 
v402 reason                # (1 not fun 2 hypo 3 paralysis 4 othr 5 inadequate 6 less pain d2) 
v403 reason                # (1 not fun 2 hypo 3 paralysis 4 othr 5 inadequate 6 less pain d3) 
v411 total dose            ### ml d1 
v412 total dose            ### ml d2  
v413 total dose            ### ml d3 
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v414 total                 ### ml 
v421 total duration        ## hrs d1 
v422 total duration        ## hrs d2 
v423 total duration        ## hrs d3 
v424 total                 ### hrs 
v431 total dose            #.# ml/hr d1 
v432 total dose            #.# ml/hr d2 
v433 total dose            #.# ml/hr d3 
v44  avr t.d               #.#  
v45  epidural removed      # pod 
v461 pea                   # (0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1) d1 
v462 pea                   # (0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1) d2 
v463 pea                   # (0 nil1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1) d3 
v464 pea                   # (0 nil1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1) d4 
v465 pea                   # (0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1) d5 
v466 pea                   # (0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1) d6 
v467 pea                   # (0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1)  d7 
v468 pea                   # (0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1)  d8 
v469 pea                   # (0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 
9 more than 1)  d9 
v471 bta                   # (0 nil1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1) d1 
v472 bta                   # 0 nil1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1) d2 
v473 bta                   # 0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1d3 
v474 bta                   # 0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1d4 
v475 bta                   # 0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1d5 
v476 bta                   # 0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1d6 
v477 bta                   # 0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1d7 
v478 bta                   # 0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1d8 
v479 bta                   # 0 nil 1 t. voveran 2 t. tram 3 inj.vov 4 inj tram 5 inj mor 6 vov patch 7 fen patch 8 others 9 
more than 1d9 
v48  pain                  ________________________________________________________________ 
v491 spiro pre op          # 1 done 2 not done 
v492 reason                #  1 icu 2 not cooperative 3 missed 4 others 
v493 pod1 spiro            #  1 done 2 not done 
v494 reason                #  1 icu 2 not coperative 3 missed 4 others 
v495 pod 3 spiro           # 1 done 2 not done 
v496 reason                # 1 icu 2 not cooperative 3 missed 4 others 
v501 fvc                   #.## po 
v502 fvc                   #.## pod1 
v503 fvc                   #.## pod3 
v511 fev1 po               #.## 
v512 fev1 pod1             #.## 
v513 fev1 pod3             #.## 
v521 fev1/fvc po           ##.# 
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v522 fev1/fvc pod1         ##.# 
v523 fev1/fvc pod3         ##.# 
v53  temp > 38.3           # 1 yes 2 no 
v54  tc > 10,000           # 1 yes 2 no 3 not done 
v541 sputum productin      # 1 yes 2 no 
v55  criteria fulfilled    # 1 yes 2 no 3 not adequate 
v56  cxr                   # 1 done 2 n.d 
v561 findings              ___________________________________ 
V562 RPT XRAY              # 1 done 2 notdone 
v563 findings              ___________________________________ 
v57  pul inf               # 1 yes 2 no 
v58  other cause fever     _________________________________________ 
v59  passed flatus         <dd/mm/yyyy> 
v60  time                  ##.## hrs 
v61  total duration        ### hrs 
v62  passed stools         <dd/mm/yyyy> 
v63  time                  ##.## hrs 
v64  total duration        ### hrs 
v65  wound inf             # 1 yes 2 no 
v66  wound inf dx pod      ## 
v67  declared fit          <dd/mm/yyyy> 
v68  hos stay              ## days 
v69  reoperation           # 1 yes 2 no 
v70  reop pod              ## 
v71  reason                ______________________________________________ 
v72  readmission           # 1 yes 2 no 
v73  readmission pod       ## 
v74  reason                ________________________________________________ 
v75  allocation no         # 1-m 2-f 
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 A B C D E F G H I J K L M N O P Q R S 
1 s.no       v2              v3           v4             v5                        v6        v7             v8           v9            v10       v11        v12        v13          v14        v15             v16         v17        v171          v18 
1              30             1               1 WEST BENGAL    1.65             50       18.4              2                          2                             2            2                                  2             2                2               1 
2              55             2               2 WEST BENGAL    1.48             37       16.9              2                          2                             2            2                                  2             2                2               1 
3              26             2               3 WEST BENGAL    1.48             37       16.9              2                          2                             2            2                                  2             2                2               1 
4              33             2               4 ASSAM                  1.31             43       25.1              2                          2                             2            2                                  2             2                2               1 
5              64             1               5 JHARKAND             1.6             69           27              2                          2                             2            2                                  2             2                2               1 
6              60             1               6 TAMILNADU        1.62             76       28.6              2                          2                             2            2                                  1             2                2               1 
7              52             1               7 JHARKAND           1.69             70       24.5              2                          2                             2            2                                  2             2                2               1 
8              55             1               8 MIZORAM            1.72             80           27              2                          2                             2            2                                  1             2                2               1 
9              57             2               9 WEST BENGAL    1.55             47       19.6              2                          2                             2            2                                  2             2                2               1 
10              60             2             10 TAMILNADU        1.51             45       19.6              2                          2                             2            2                                  2             2                2               1 
11              30             2             11 WEST BENGAL    1.44             42       20.3              2                          2                             2            2                                  2             2                2               2 
12              36             1             12 bihar                     1.64             53       19.7              2                          2                             2            2 no                            2             2                2               2 
13              66             2             13 ANDHRA PRAD   1.44             53       25.6              2                          2                             2            2 CA ENDOM            1             2                1               1 
14              69             1             14 TAMIL NADU       1.42             41           20              2                          2                             2            2                                  1             2                2               1 
15              54             1             15 WEST BENGAL    1.59             51       20.2              2                          2                             2            2                                  1             2                2               1 
16              30             2             16 tamilnadu            1.52             52       22.5              2                          2                             2            2                                  2             2                2               1 
17              48             1             17 west bengal         1.54             54       22.8              2                          2                             2            2                                  2             2                2               1 
18              60             1             18 JHARKHAND        1.72             74           25              2                          1        174              2            2                                  1             2                2               1 
19              52             1             19 MEGHALAYA       1.57             70       28.4              2                          2                             2            2                                  2             2                2               1 
20              31             2             20 BANGLADESH      1.53             56       23.9              2                          2                             2            2                                  2             2                2               1 
21              59             1             21 WEST BENGAL    1.61             65       25.1              2                          1          24              2            2                                  2             2                2               2 
22              35             1             22 WEST BENGAL    1.64             47       17.5              2                          1          12              2            2                                  2             2                2               1 
23              40             1             23 WEST BENGAL    1.62             50       19.1              2                          2                             2            2                                  2             2                2               1 
24              59             2             24 BANGLADESH      1.48             60       27.4              2                          2                             2            2                                  2             2                2               1 
25              37             2             25 WEST BENGAL    1.51             47       20.6              2                          2                             2            2                                  2             2                2               1 
26              35             1             26 WEST BENGAL    1.73             63           21              2                          2                             2            2                                  2             2                2               1 
27              62             1             27 JHARKHAND        1.69             55       19.3              2                          2                             2            2                                  2             2                2               1 
28              70             2             28 WEST BENGAL    1.48             37       16.9              1         25            2                             2            1 HONEY CO             2             2                2               1 
29              51             2             29 WEST BENGAL    1.52             56       24.2              2                          2                             2            2                                  2             1                2               1 
30              30             2             30 WEST BENGAL       1.5             35       15.6              2                          2                             2            2                                  2             2                2               2 
31              57             1             31 WEST BENGAL    1.65             70       25.7              2                          2                             2            2                                  2             2                2               1 
32              34             1             32 BANGLADESH      1.72             62           21              2                          2                             2            2                                  2             2                2               1 
33              40             2             33 WEST BENGAL       1.6             67       26.1              2                          2                             2            2                                  2             2                2               1 
34              25             2             34 TAMILNADU        1.39             45       23.3              2                          2                             2            2                                  2             2                2               2 
35              55             2             35 west bengal         1.48             49       22.4              2                          2                             2            2                                  2             2                2               1 
36              43             2             36 jharkhand            1.47             36       16.7              2                          2                             2            2                                  2             2                2               2 
37              56             1             37 WEST BENGAL    1.74             81       26.8              1         20            2                             2            2                                  2             2                2               2 
38              43             2             38 WESTBENGAL      1.52             52       22.5              2                          2                             2            2                                  2             2                2               1 
39              16             1             39 TAMILNADU        1.34             25       13.9              2                          2                             2            2                                  2             2                2               2 
40              49             2             40 JHARKHAND        1.56             42       17.3              2                          2                             2            2                                  2             2                2               2 
41              56             1             41 ORISSA                 1.67             55       19.7              2                          2                             2            2                                  2             2                2               1 
42              69             1             42 WEST BENGAL    1.63             59       22.2              2                          1        120              2            2                                  2             2                2               1 
43              39             1             43 WEST BENGAL    1.58             63       25.2              2                          1            2              2            2                                  2             2                2               2 
44              57             1             44 ARUNACHAL P    1.59             55       21.8              2                          2                             2            2                                  2             2                2               1 
45              46             1             45 TAMILNADU        1.69             67       23.5              2                          2                             2            2                                  2             2                2               1 
46              70             1             46 TAMILNADU                             48                              2                          2                             2            2                                  2             2                2               1 
47              41             1             47 WEST BENGAL    1.55             55       20.8              1         10            2                             2            2                                  1             2                2               1 
48              52             1             48 bangladesh                               60                              2                          2                             2            2                                  1             2                2               1 
49              55             2             49 JHARKHAND          1.5             62       27.6              2                          2                             2            2                                  2             2                2               1 
50              42             1             50 WEST BENGAL    1.69             61       22.4              2                          2                             2            2                                  2             2                2               1 
51              51             1             51 JHARKHAND          1.7             54       18.7              2                          2                             2            2                                  2             2                2               1 
52              53             1             52 WEST BENGAL    1.58             50           20              1         30            2                             2            1                                  2             2                2               1 
53              73             1             53 TAMILNADU          1.5             42       18.7              1         50            2                             2            1                                  2             2                2               1 
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21 
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23 
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26 
27 
28 
29 
30 
31 
32 
33 
34 
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36 
37 
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39 
40 
41 
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 T U V W X Y Z AA AB AC AD AE AF AG AH AI AJ AK AL 
1 v19        v20                          v21          v22                     v23       v24       v251       v252         v253          v26            v27       v28       v29           v30        v31        v32           v33        v34    v35 
1           26/08/2010              1 APPENDICECTO          1           2       14.4        16.25            105              12           1           4             13            3            2               0            3 B                   2 
1           02/09/2010              1 GYNACOLOGY             1           2     13.55        16.45            150              10           1           3               6            3            1               0            3 B                   2 
2           16/09/2010              1 LSCS                              1           2       11.3              14            150              12           1           5             14            3            2               0            3 B                   2 
2           11/10/2010              1 LSCS                              2           2             8              11            180              15           1           5             13            3            1               0            3 B                   2 
1           21/10/2010              2                                        2           2       8.15        10.45            150              10           1           4             13            3            0               0            2 A                   2 
1           01/11/2010              1 HERNIOPLASTY           1           2           11              14            180              12           1           5               9            3            2               0            3 B                   2 
1           22/11/2010              2                                        1           2           10          12.3            150              10           1           7             14            3            2               0            3 B                   2 
1           09/12/2010              2                                        1           2          8.1          10.1            120              10           2           6             37            4            0               0            2 B                   2 
1           06/01/2011              2                                        2           2       10.1          12.4            150                8           1           3             15            3            0               0            2 A                   2 
3           10/12/2011              1 TUBECTOMY               3           2           10          11.3               90              10           2           5             11            2            0               0            1                       2 
3           13/01/2011              1 TUBECTOMY               3           2     13.15        15.15            120                8           1           7 
1           20/01/2011              1 appendicectom          1           2       8.15        10.15            120              20           1           6 
1           27/01/2011              1 TAH + BSO                   1           2           13              16            180              11           1           4               8            3            0               0            2 A                   2 
1           27/01/2011              1 LSCS                              2           2     13.15          16.3            195              12           1           2             18            4            2               0            3 C                   2 
3           31/01/2011              2                                        3           2           10              13            180              13           1           5             14            4            0               0            2 C                   2 
1           10/02/2011              2                                        1           2             8              11            180              12           1           4             15            4            2                              3 c                   2 
1           10/03/2011              2                                        1           2           11          13.3            150              12           2           4             15            3            0               0            2 a                   2 
1           04/04/2011              2                                        1           2       8.15          10.4            145              10           2           4             19            4            0               0            2 B                   2 
5           07/04/2011              2                                        5           2           12        15.45            240              13           2           7 
1           07/04/2011              2                                        2                      14.3        16.45            135              10           1           3             11            4            2               0            3 C                   2 
1           02/05/2011              2                                        1           1             9          11.3            150              11                          3 
1           12/05/2011              2                                        1           2       14.4          16.1               90              10           1           3             11            0            0               0                                      2 
1           06/06/2011              2                                        1           2           13          14.3               90              10           2           4             22            3            0               0            2 A                   2 
2           30/06/2011              2                                        1           2           10        12.45            165              10           1           6             18            4            0               0            2 B                   2 
1           30/06/2011              1 GYNACOLOGIC           1           2             9          10.3               90                9           1           5             12            3            0               0            2 A                   2 
1           11/07/2011              2                                        1           2           10              12            120              10           1           3             15            3            1               0            3 B                   2 
1           01/08/2011              2                                        1           2     14.45              17            135                9           1           4             27            3            0               0            2 A                   2 
1           22/08/2011              2                                        1           1           12              14            120              13           1           5             19            3            0               0            2 A                   2 
1           22/08/2011              1 TAH+ BSO                    1           2       12.4          15.5            190              18           1           5             10            4            1               0            3 B                   2 
1           08/09/2011              2                                        1           2           13          15.3            150              13           1           4 
1           09/09/2011              1 APPENDICECTO          1           2           12              14            120              12           1           5             13            4            0               0            2 B                   2 
1           15/09/2011              2                                        1           2           13              15            120              15           1           4             22            4            2               0            3 C                   2 
3           19/09/2011              1 APPENDICECTO          3           2          8.3          11.3            180              13           1           5               8            4            1               0            3 B                   2 
2           22/09/2011              1 HERNIA REPAIR          1           2       14.3              17            150              12           1           5 
1           23/09/2011              2                                        1           2           13              15            120              10           1           3             12            3            0               0            2 a                   2 
1           10/10/2011              2                                        1           2       13.3              16            150              10           1           1 
1           21/11/2011              2                                        1           2             9              11            120              10           1           4 
1           08/12/2011              1 lscs sterlization           1           2           13              15            120              11           1           2             14            3            1                              3 b                   2 
1           27/01/2012              2                                        1           2           12          13.3               90                9           1           4 
1           20/01/2012              1 LSCS                              1           1       12.3              15            150              10                          4 
1           23/02/2012              2                                        1           2           10          12.3            150              14           1           4             13            3            1               0            3 B                   2 
2           01/03/2012              2                                        2           1       12.3              15            150              11           1           4             11            4            1               0            3 B                   2 
1           12/03/2012              1 APPENDICECTO          1           2       13.5          16.3            160              10           1           3 
1           16/03/2012              1 APPENDICECTO          1           2           15          16.3               90                8           1           4             16            3            1               0            3 B                   2 
1           02/04/2012              2                                        1           2           13              15            120              10           1           4             13            3            1               0            3 B                   2 
2           02/04/2012              2                                        1           2           11        13.15            150              11           1           1             18            1            0               0            1                       2 
2           18/04/2012              2                                        1           2           10          12.3            150              12           1           2             38            3            1               0            3 B                   2 
1           23/04/2012              1 laparoscopic ch          1           2       14.3          16.3            120              10           1                           17            3            0               0            2 a                   2 
1           25/04/2012              2                                        1           2           10              12            120              11           1           4             31            2            0               0            1                       2 
1           03/05/2012              2                                        1           2       12.3              15            150              10           2           7             19            3            0               0            2 A                   2 
1           28/05/2012              2                                        1           2       14.3              16               90              10           2           8             18            3            0               0            2 A                   2 
1           04/07/2012              2                                        1           2           12          14.3            150                9           1           3             17            4            0               0            2 B                   2 
1           04/07/2012              2                                        1           2           15          17.3            150              11           1           3             23            4            2               0            3 C                   2 
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 AM AN AO AP AQ AR AS AT AU AV AW AX AY AZ BA BB BC BD BE BF 
1 v36      v361      v362          v363           v364    v365          v366     v367      v368      v369      v37        v381        v382      v383         v391       v392     v393    v401    v402      v403 
2            7                 8                  3           1                1                                                                         4               7            5                5                            1                                       2 
2            4                 2                  1           0                                                                                         1.7               5            5                5 
2            1                 1                  1           0                                                                                         0.7               5            5                5             2            2           2 
2            3                 1                  5           2                2                                                                      2.6               5            3                3             2            1           2                          2 
2            1                 3                  2           3                6                                                                         3               5            5                5             2            2           2 
2            7                 2                  2           1                3                                                                         3               4            4                4             2            2           2 
2            2                 4                  3           3                3                                                                         3               5            5                5             2            2           2 
2            4                 2                  1           2                0                                                                      1.8               5            4                4             1                                      2 
2            2                 4                  3           1                                                                                         2.5               5            6                6             1                                      5 
2            0                 2                  2           1                1                                                                      1.2               5            5                5             2            2           2 
2                 2                  1           2                1            2                                                       1.6               4            4                                2            2           1                                         1 
3                 3                  1           1                0                                                                      1.6               5            6                6             1            1           1           6             2            2 
2            1                 2                  3           3                4                                                                      2.6               5            4                4             2            1           2                          6 
2            2                 1                  0           2                                                                                         1.2               6            5                5             2            1           2                          6 
2            2                 5                  5           3                                                                                         3.7               7            7                0             2            1                                       1 
2            2                 1                  1           1                1                                                                      1.2            3.5         2.5            3.5             2            1           1                          2            5 
2            2                 2                  1           2                1            1                                                       1.5               5            5                5             2            2           2 
2            2                 1                  1           1                                                                                         1.2               5            5                5             2            2           2 
4                 2                  2           1                                                                                         2.2               5            5                5             2            2           2 
2            2                 2                  1           1                1                                                                      1.4               5            5                5             2            2           2 
4                 3                  3           2                                                                                            3               5            6                6             2            1           2                          5 
2            6                 2                  1           1                1                                                                      2.2               5            8                8             1            2           2           5 
2            6                 3                  2           1                                                                                            3               5            5                5             2            2           2 
2            2                 1                  2           1                                                                                         1.5               5            5                5             2            2           2 
2            2                 2                  1           1                                                                                         1.5 
2            3                 2                  1           1                                                                                         1.7               5            4                3             2            1           1                          6            6 
2            1                 2                  1           0                1                                                                         1               5            5                5             2            2           2 
2            4                 3                  5           4                                                                                            4               5            5                5             2            2           2 
2            6                 1                  1           1                                                                                         2.2               5                                               1                                      1 
6                 3                  3           2                                                                                         3.5               5                                               1                                      1 
2            4                 3                  2           1                                                                                         2.5               6            5                5             1            2           2           2 
2            2                 1                  1           1                                                                                         1.2               5            5                5             2            1           2                          4 
2            5                 5                  3           2                1                                                                      3.2               5            7                7             1            2           2           5 
2                 2                  2           3                                                                                         2.2               4            4                4             2            2           2 
2            1                 2                  1           1                1                                                                      1.2               5            5                5             2            2           2 
2                 5                  1           1                                                                                         2.2               4            3                3             2            1                                       2 
3                 2                  1           1                                                                                         1.7               4            4                6             2            2           1                                         5 
2            2                 2                  1           1                1                                                                      1.4               5            3                3             2            1           2                          2 
4                 3                  2           1                0                                                                         2               4                                               1                                      1 
4                 3                  3           1                0                                                                      2.2               5                                               1                                      2 
2            4                 3                  2           1                1                                                                      2.2               5                                               1                                      2 
2            2                 1                  1           1                1                                                                      1.2               5            5                5             2            2           2 
1                 0                  0           2                                                                                         0.6               5            4                4             2            1           2                          6 
2            3                 2                  2           2                2                                                                      2.2               4            4                4             2            2           2 
2            2                 1                  3           2                3                                                                      2.2               5            5                5             2            2           2 
2            2                 3                  1           1                0                                                                      1.4               4            3                5             1            1           1           2             6            6 
2            4                 3                  2           3                2                                                                      2.8               5            5                5             2            2           2 
2            3                 2                  1           1                2                                                                      1.8 
2            4                 3                  3           2                1                                                                      2.6               5            5                5             2            2           2 
2            3                 2                  2           3                2                                                                      2.4               5            5                5             2            2           2 
2            3                 1                  1           1                1                                                                      1.4               4            5                5             2            1           2                          5 
2            2                 1                  1           1                1                                                                      1.2               5            5                5             2            2           2 
2            4                 4                  3           2                2                                                                         3               5                                               1                                      2 
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 BG BH BI BJ BK BL BM BN BO BP BQ BR BS BT BU BV BW BX BY BZ CA CB 
1 v411        v412      v413      v414        v421      v422     v423      v424      v431    v432    v433        v44       v45      v461     v462      v463    v464      v465     v466     v467       v468    v469 
84        152        120          356          12          24          24          60           7        6.1               5           6           4                                                       1 
60        120        120          300          12          24          24          60           5           5               5           5           4                                                       9           1           1 
70        120        120          310          14          24          24          62           5           5               5           5           4                                                       1           1 
90           78           72          240          18          24          24          66           5        3.2               3        3.7           4                                                       3 
95        120        120          335          19          24          24          67           5           5               5           5           4                                                       3           3 
60           96           96          252          15          24          24          63           4           4               4           4           4                                                       1           1           1 
85        120        120          325          17          24          24          65           5           5               5           5           4                                                       3           3           3 
82           96           96          274          18          24          24          66        4.3           4               4        4.1           4                                                       3           3 
92        144        144          380          16          24          24          64        5.7           6               6        5.9           4                                                       1           1           1 
90        120        120          330          18          24          24          66           5           5               5           5           4                                                       1           1 
48           96             8         152          12          24          24          60           4           4               4           4           3                                        5            3           1 
104        120        120          344          18          20          20          58        5.7           6               6        5.9           4           0            0           0            0           0           0 
65           98           96          259          13          24          24          61           5           4               4        4.3           4                                                       5           4           4 
72        123        120          315          12          24          24          60           6        5.1               5        5.3           4                                                       3           3           1 
112           21                         133          16            3                         19           7           7                            7           2                           5           5            5           1 
63           64           80          207          18          24          24          66        3.5        2.6           3.3        3.1           4                                                       5           5           8 
80        120        120          320          16          24          24          64           5           5               5           5           4                                                       1           1           1 
95        120        120          335          19          24          24          67           5           5               5           5           4                                                       3           3           2             2 
70        120        120          310          14          24          24          62           5           5               5           5           4                                                       3           1           1 
65        120        120          305          13          24          24          61           5           5               5           5           4                                                       3           1           1 
90        141        144          375          18          24          24          66           5        5.9               6        5.6           4                                                       3           1           1 
84        192        192          468          12          24          24          60           7           8               8        7.6           4                                                       1 
75        120        120          315          15          24          24          63           5           5               5           5           4                                                       1           1 
80        120        120          320          16          24          24          64           5           5               5           5           4                                                       5           5 
5            5           5            3           1 
90           99           75          264          18          24          24          66           5        4.1           3.1           4           4           0                                         1           1 
70        120        120          310          14          24          24          62           5           5               5           5           4                                                       5           5           1 
80        120        120          320          16          24          24          64           5           5               5           5           4                                                       3 
20                                                            4                                          4           5                                          5           1           5            5           3            2 
25                                           25            5                                          5           5                                          5           1           4            4           4            3           1 
78        120        120          318          15          24          24          63        5.2           5               5        5.1           4                                                       1           1 
75        110        120          305          15          22          24          61           5           5               5           5           4                                                       3           1 
116        168        168          452          18          24          24          66        6.4           7               7        6.8           4                                                       3           3           1 
48           96           96          240          12          24          24          60           4           4               4           4           4                                                       3           1 
70        120        120          310          14          24          24          62           5           5               5           5           4           0            0           0            0           0           0             0           0           0 
48           66             9         123          12          21            3          38           4        3.1               3        3.4           3                                        3            1           1 
72           96        138          306          18          24          24          66           4           4           5.7        4.5           4                                                       1           1 
90           78           72          240          18          24          24          66           5        3.2               3        3.7           4                                                       3           1           1 
20                                           20            5                                          5           4                                          4           1           5            5           5            1           1           1 
10                                           10            2                                          2           5                                          5           1           8            8           8            5           5           4             2 
10                                           10            2                                          2           5                                          5           1           8            8           8            8           5           4             2 
70        120        120          310          14          24          24          62           5           5               5           5           4                                                       1           1 
60           99           96          255          12          24          24          60           5        4.1               4        4.3           4                                                       1 
52           96           96          244          13          24          24          61           4           4               4           4           4                                                       2           2           2             2 
70        120        120          310          14          24          24          62           5           5               5           5           4                                                       3           1           1             1 
34           69        112          215          13          24          24          61        2.6        2.8           4.6        3.3           4                                                       3           1 
85        120        120          305          17          24          24          65           5           5               5           5           4                                                       4           2 
8            8           2            2           2           2 
90        120        120          330          18          24          24          66           5           5               5           5           4                                                       3           1 
75        120        120          315          15          24          24          63           5           5               5           5           4                                                       5           5 
48        117        120          285          12          24          24          60           4        4.9               5        4.6           4                                                       1           1 
75        120        120          315          15          24          24          63           5           5               5           5           4                                                       5           5           1 
20                                           20            4                                          4           5                                          5           1           8            8           8            3           1 
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 CC CD CE CF CG CH CI CJ CK CL CM CN CO CP CQ CR CS CT CU 
1 v471    v472      v473       v474    v475      v476        v477       v478       v479        v48                                       v491       v492    v493     v494    v495      v496     v501         v502        v503 
3                                                                                                                                                                         1                          1                          1                        3.42         1.04           1.97 
2             2                                                                                                MOROHINE D4                              1                          2           2            2           2          2.16 
0             0             0                                                                                                                                                         1                          1                          1                        2.23         2.21           1.18 
3             3             3                                                                                                                                                         1                          1                          1                        2.91         1.04           1.61 
0             0             0                                                                                                                                                         1                          1                          1                          2.9         1.23           1.97 
3             3             3                                                                                                INJ. VOVERAN 50MG TID            1                          1                          1                        2.64         1.45             1.5 
0             0             0                                                                                                                                                         1                          1                          1                        3.28         1.78           2.04 
3             3                                                                                                               INJ. VOVERAN FOR BTA               1                          1                          1                        3.76         2.42           3.17 
3                                                                                                                               1 DOSE INJ. VOVERAN                 1                          1                          1                        2.22         0.95           1.18 
0             0             0                                                                                                                                                         1                          1                          1                          0.9         0.66           0.96 
0             0                                                                                                               EPIDURAL LINE CAME O              1                          1                          1                        2.19         1.61           1.85 
0             0             0           0            0              0             0             0              0                                                           1                          1                          2           3          3.56         1.82 
7             7                                                                                                PT WAS GIVEN FEN PATC            1                          1                          1                        1.71         1.02           0.83 
0             0             0                                                                                                                                                         1                          1                          1                        1.38         0.81           1.04 
6             6                                                                                                               EPI NOT WORKING. MOR           1                          1                          1                        3.32         1.22           1.31 
3             3                                                                                                               c.proxyvon                                     1                          1                          1                          2.4         0.98           0.84 
0             0             0           0            0                                                                                                                            1                          1                          1                        2.14           1.3             0.8 
0             0             0           0            0                                                                                                                            1                          1                          2           2          3.67           2.2 
0             0             0           0            0              0             0                                                                                                                        1                          1                        2.89         2.35             2.9 
0             0             0           0            0              0                                                                                                            1                          1                          1                        2.53         1.98           0.89 
0             3             3                                                                                                1 DOSE EACH DAY                        1                          2           2            2           2          3.12 
3             0             0           0            0              0             0                                  INJ. VOVERAN 3 DOSES               1                          2           2            2           2          3.39 
0             0             0           0                                                                                                                                           1                          2           3            2           3          2.99 
0             0             0           0            0                                                                   INJ. MORPHINE 5MG S/C            1                          1                          1                          2.1         1.39                1 
EPIDURAL NOT PUT. MO             1                          2           1            1                        2.68                            0.94 
0             0             0           0                                                                                                                                           1                          1                          1                          3.6           2.2           3.15 
4                                                                                                                               MORPHINE 5MG S/C 2 D            1                          1                          1                        3.83         2.63           3.39 
5             5             0           5                                                                                  TOTAL 4 DOSES OF MOR             1                          1                          1                        2.23         1.35             1.8 
0             0                                                                                                               NON FUN EPI REMOVED             1                          1                          1                        2.64         1.29           1.63 
5                                                                                                                               EPI NOT WORKING CAHN           1                          1                          1                        1.98         0.58           1.18 
0             5                                                                                                PEA T.ULTRA CET ALON               1                          1                          1                        3.53         2.49           1.63 
5           5                                                                                  MOR 5MG S/C Q4H FOR             1                          1                          1                        3.86         1.72           1.64 
0             3             3                                                                                                INJ. VOV 50MG IV TID D              1                          1                          1                        2.41         1.41           1.66 
0             5                                                                                                               1 DOSE INJ. MORPHINE               1                          1                          1                        1.94           0.7           0.76 
0                                                                                                                                                                                         1                          2           2            1                        2.03                              1.5 
3                                                                                                               bta Inj. Voveran 2 doses             1                          1                          1                        1.94         1.01           1.05 
0             0             0                                                                                                EPI INCREASED TO 6ML/             1                          2           3            2           3          3.45 
0             0             5                                                                                                pod 3 inj. morphine 1 do            2           4            2           4            2           4 
0             0             0           0            0                                                                   MOR 2.5 MG S/CQ4H PO            1                          1                          1                        1.79         1.25           0.86 
0             0           0            0              0                                                  FENTA MIDAZ INFUSION             1                          2           1            2           1          1.91 
0           0            0              0             0             0                  ICU EPI REMOVED FENT              1                          2           1            1                        3.28                            1.85 
0             0             0           0                                                                                                                                           1                          1                          1                        1.49         1.61           1.59 
0             0             0           0                                                                                                                                           2           4            2           4            2           4 
0             0             0                                                                                                                                                         1                          1                          1                        3.29         2.31           2.45 
0             0             0                                                                                                                                                         1                          1                          1                        3.13         2.05           2.64 
0             0             0           0                                                                                                                                           1                          1                          1                        2.16           1.5           1.54 
5             0             0           0            0                                                                   FENTANYLPATCH. MORP            1                          1                          1                        3.52           2.5           1.89 
3             3                                                                                                               dosifusion 48hrs. + inj. v             2           4            1                          1                                         1.13           0.89 
0             0             0           0                                                                                                                                           1                          1                          1                          1.8         0.92           1.23 
0             0             0                                                                                                                                                         1                          1                          2           2          3.92         1.86 
0             0             0           0                                                                                                                                           1                          1                          1                        3.67         3.77           3.69 
0             0             0           0                                                                                                                                           1                          1                          1                        3.39         2.15           2.88 
FENTANYL INFUSION IN I            1                          2           1            1                        1.95                            1.13 
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 CV CW CX CY CZ DA DB DC DD DE DF DG DH DI DJ DK DL DM DN 
1 v511     v512    v513        v521     v522        v523      v53     v54      v541        v55          v56        v561      v562        v563     v57        v58               v59                    v60    v61 
3.05     0.79        1.69      89.2        75.4       85.6          2          1              2              2            2                             2                           2                           28/08/2010      10          42 
1.83                                     79.8                                          2          2              2              2            2                                                           2                           05/09/2010        7          62 
2.21        0.9        1.07      99.2        95.7       90.7          2          1              2              2            2                                                           2                           18/09/2010      18          39 
2.18     0.69           1.2          75        66.3       74.9          2          2              2              2            2                                                           2                           13/10/2010      20          57 
2.32     0.91           1.6      79.9        74.6       81.2          2          1              2              2            2                                                           2                           04/11/2010        8        360 
2.11     1.15        1.33      79.9        79.4           89          2          1              2              2            2                                                           2                           04/11/2010      11          69 
2.66     1.45        1.64      81.3        81.7       80.5          1          1              2              1            1 NIL                      2                           2 ANASTOMO    24/11/2010      18          53 
2.96     1.95        2.52      79.1        80.7       79.5          2          1              2              2            2                                                           2 WOUND IN     12/12/2010        9          70 
1.91     0.82        1.01      86.1            86       85.3          2          2              2              2            2                                                           2 WOUND IN     08/01/2011     2.3          38 
0.87     0.65        0.78          97        99.1       81.2          2          1              2              2            2                             2                           2 NO                    15/01/2011      10          46 
2.18     1.47        1.56      99.5        91.1           84          2          1              2              2            2                             2                           2 NO                    16/01/2011      11          67 
3.17     1.74                          89        95.4                         2          2              2              2            2                                                           2                           21/01/2011      11          36 
1.52     0.92        0.64      88.7        89.9       77.1          1          2              1              1            1 NIL                      1 NIL                   2 WOUND IN     04/02/2011      16        192 
1.18     0.63        0.82      85.6        78.1           79          2          1              2              2            2                             2                           2 WOUND IN     30/01/2011      17          72 
2.8     0.93        1.19      84.3        76.5       91.2          2          3              2              2            2                                                           2 NIL                    04/02/2011      12          94 
2.1     0.83        0.72      87.5            85       85.6          2          2              2              2            2                                                           2                           13/02/2011        8          69 
1.68     1.04        0.55      78.7        79.8       69.5          2          1              2              2            2                                                           2                           12/03/2011        6          40 
2.91        1.1                       77.8        50.7                         1          1              2              1            1 NIL                      2                           2 UTI, CENTR     05/04/2011      21          34 
2.16     1.78        2.14      74.9        75.6       73.8          2          2              2              2            2                                                           2                           09/04/2011      18          50 
2.29     1.72        0.53      90.4        86.6       60.1          2          1              2              2            2                                                           2                           11/04/2011      18          98 
2.42                                     77.4                                          2          2              2              2            2                                                           2                           06/05/2011      10          94 
2.68                                        79                                          1          2              2              2            2                                                           2                           15/05/2011        8          63 
2.88                                     96.3                                          2          1              2              2            2                                                           2                           09/06/2011      16          73 
1.7     1.11        0.96      80.8        79.9       79.9          2          3              2              2            2                                                           2                           02/07/2011      18          77 
2.26                        0.6      84.3                        64.1          1          1              2              1            1 NIL                      2                           2 LINE SEPSIS     02/07/2011      18          55 
2.9     1.53        2.58          88        69.6           82          2          3              2              2            2                                                           2                           13/07/2011      14          50 
2.95     2.07        2.61      77.1        78.6           77          2          1              2              2            2                             2                           2                           05/08/2011      10          90 
1.73     1.13        1.36      77.5        78.7       78.7          2          1              2              2            2                                                           2 
2.38     1.19        1.63      95.3            99       82.4          2          2              2              2            2                                                           2                           24/08/2011      16          48 
1.98     0.56        1.04          99        69.1       88.1          1          2              2              2            2                                                           2                           11/09/2011      18          75 
2.75           2        1.17      77.3        76.1       72.2          2          3              2              2            2                                                           2                           11/09/2011        7          41 
3.26     1.51        1.36      84.4        88.1       82.6          2          1              2              2            2                             2                           2                           17/09/2011        9          42 
1.9     1.07        1.24      78.9        80.9       83.5          2          3              2              2            2                             2                           2                           22/09/2011      11          71 
1.51     0.61        0.55      83.4        71.4       72.2          2          2              2              2            2                             2                           2                           24/09/2011      18          48 
1.67                      1.16      91.9                        69.1          2          1              2              2            2                             2                           2                           26/09/2011      15          72 
1.75     0.94        0.91      90.1        92.9           86          2          2              2              2            2                                                           2                           12/10/2011        6          38 
2.91                                     84.3                                          2          1              2              2            2                                                           2                           23/11/2011      18          55 
2          1              2              2            2                             2                           2                           10/12/2011      18          51 
1.62     0.91        0.66      90.6        90.5       76.4          2          1              2              2            2                                                           2                           30/01/2012        9          67 
1.62                                        84                                          2          1              1              1            1 PATCH               2                           1 
2.79                      1.36      85.6                        74.7          2          2              2              2            1 NIL                                                   2                           26/02/2012      18          77 
1.17     1.25        1.29      78.7        77.3       81.4          2          1              2              2            2                             2                           2                           03/03/2012      10          43 
2          1              2              2            2                             2                           2                           14/03/2012      16          47 
2.67     1.34        1.65      83.5        58.1       67.5          2          1              2              2            2                             2                           2                           19/03/2012        9          64 
2.84        1.8        2.19      95.3        99.8       98.7          2          1              2              2            2                             2                           2                           05/04/2012        9          66 
1.79     1.32        1.26      82.9            89       78.1          2          1              2              2            2                             2                           2                           06/04/2012      19        101 
2.89     2.03        1.48      82.4        83.8       78.9          2          2              2              2            2                                                           2                           22/04/2012        6          89 
1.08        0.86                       89.7       81.5          1          2              2              2            2                             2                           2                           28/04/2012        9        112 
1.66        0.9        1.09      83.3        96.7       90.9          2          3              2              2            2                             2                           2                           27/04/2012      21          57 
3.04     1.42                       76.7        76.4                         2          2              2              2            2                             2                           2                           12/05/2012 
2.83     2.93        2.97      76.3        79.1       80.4          2          2              2              2            2                             2                           2                           30/05/2012      10          42 
2.37     1.39        2.37      69.8        64.9       82.4          2          1              1              1            2                             2                           1 CLINICAL          06/07/2012      21          54 
1.62                      0.79      82.7                        69.5          2          1              2              2            2                             2                           2                           07/07/2012      22          77 
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 DO DP DQ DR DS DT DU DV DW DX DY DZ EA EB 
1 v62                          v63    v64       v65        v66       v67                          v68    v69       v70     v71     v72       v73     v74                     v75 
30/08/2010      12         92            2                         30/08/2010         5           2                                   2                                                1 
05/09/2010         9         64            2                         05/09/2010         4           2                                   2                                                2 
20/09/2010         9         91            2                         20/09/2010         5           2                                   2                                                2 
14/10/2010      16         77            2                         15/10/2010         5           2                                   2                                                1 
05/11/2010         5       384            1           4           05/11/2010       16           1         5 ANAS           2                                                1 
04/11/2010   19.3         77            2                         06/11/2010         6           1       12 ANAS           1       12 ANASTOMOTIC       1 
25/11/2010      21         80            2                         26/11/2010         5           1         8 ANAS           1         8 FEVER ANASTO       1 
13/12/2010         8         93            1           4           13/12/2010         5           2                                   2                                                2 
08/01/2011     3.3         39            1           4           09/01/2011       14           2             STAY            2                                                2 
16/01/2011   16.3         77            2                         16/01/2011         4           2                                   2                                                2 
17/01/2011         9         89            2                         17/01/2011         5           2                                   2                                                2 
22/01/2011      14         51            2                         25/01/2011         6           2                                   2                                                1 
05/02/2011      16       216            1           5           09/02/2011       14                           PUL E           2                                                2 
30/01/2011      22         77            1           4           01/02/2011         5           2                                   2                                                2 
04/02/2011      22       104            2                         05/02/2011         6           2                                               2                                    1 
14/02/2011         7         92            2                         15/02/2011         6           2                                   2                                                1 
13/03/2011      16         74            2                         17/03/2011         8           2                                   2                                                1 
06/04/2011      10         47            2                         21/04/2011       17           2             SEPSIS PROLONGED HOSPITAL STAY       2 
10/04/2011      19         75            2                         11/04/2011         5           2                                   2                                                1 
12/04/2011         8       112            2                         12/04/2011         6           2                                   2                                                2 
07/05/2011      12       120            1           3           07/05/2011         6           2                                   2                                                1 
15/05/2011      18         73            2                         16/05/2011         6           2                                   2                                                1 
10/06/2011      14         95            2                         10/06/2011         5           2                                   2                                                1 
05/07/2011      10         93            2                         05/07/2011         6           2                                   2                                                2 
03/07/2011      14         76            2                         14/07/2011       15           1         5 ? ANA          2                                                2 
15/07/2011         4         88            2                         15/07/2011         5           2                                   2                                                2 
06/08/2011      19       124            2                         06/08/2011         6           2                                   2                                                2 
2                         26/08/2011         5           2             HAD I           2                                                1 
26/08/2011         9         89            1           6           26/08/2011         5           2                                   2             STAY PROLONG      2 
13/09/2011         8       114            2                         13/09/2011         6           2                                   2                                                1 
11/09/2011         9         43            2                         15/09/2011         7           2             LOOSE STOOLS REQUIRED IV FLUIDS      1 
19/09/2011         9         90            1           3           19/09/2012         5           2                                   2                                                2 
24/09/2011         8       116            2                         24/09/2011         6           2                                   2                                                1 
25/09/2011      18         72            2                         26/09/2011         5           2                                   2                                                1 
26/09/2011      22         79            2                         27/09/2011         5           2                                   1         8 Uro sepsis                2 
12/10/2011      11         43            2                         13/10/2011         4           2                                   1         9 fever. antibioti        2 
24/11/2011      16         77            2                         24/11/2011         4           2                                   2                                                2 
12/12/2011         8         89            2                         12/12/2011         5           2                                   2                                                2 
30/01/2012      10         68            2               03/02/1012                   8           2             PARALYTIC ILEUS WITH VOMITING          1 
25/02/2012                                      2                         27/02/2012         8           2             MI ICU         2                                                1 
27/02/2012      22       105            2                         28/02/2012         6           2             ICU, H          2                                                1 
04/03/2012         2         59            2                         04/03/2012         4           2             STOM          2                                                2 
15/03/2012      10         65            2                         15/03/2012         4           2                                   2                                                2 
20/03/2012      14         93            1           4           20/03/2012         5           2             ACTU           2                                                2 
06/04/2012      10         89            1           4           16/04/2012       15           1         8 ANAS           2                                                2 
07/04/2012      10       116            2                         07/04/2012         6           2                                   2                                                1 
22/04/2012      22       105            2                         23/04/2012         6           2                                   2                                                1 
29/04/2012      13       140            1           4           29/04/2012         7           2             wpw s          2                                                2 
28/04/2012         8         68            1           4           28/04/2012         4           2                                   2                                                1 
12/05/2012                                      2                         14/05/2012       12           1         5 ANAS           2                                                2 
30/05/2012      18         50            2                         30/05/2012         3           2                                   2                                                2 
08/07/2012      18         96            2                         08/07/2012         5           2                                   2                                                2 
08/07/2012         9         86            1           4           11/07/2012         8           2             LOOSE         2                                                1 
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